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Résumé pour un large public 
La vaccination a eu un impact énorme sur la santé mondiale. Mais, quel est le principe d’un 
vaccin? Il est basé sur la ‘mémoire immunologique’, qui est une particularité exclusive des 
systèmes immunitaires des organismes évolués. Suite à une infection par un pathogène, des 
cellules spécialisées de notre système immunitaire (les lymphocytes) le reconnaissent et initient 
une réaction immunitaire qui a pour but son élimination. Pendant cette réaction se développent 
aussi des cellules, appelées cellules lymphocytaires mémoire, qui persistent pour longue durée et 
qui ont la capacité de stimuler une réaction immunitaire très efficace immédiatement après une 
seconde exposition à ce même pathogène. Ce sont ces cellules mémoires (lymphocytes B et T) 
qui sont à la base de la ‘mémoire immunologique’ et qui sont stimulées lors de la vaccination. 
Chez l’homme, deux populations distinctes des lymphocytes T mémoires ont été identifiées: les 
cellules centrales (CM) et effectrices (EM) mémoires. Ces populations sont fonctionnellement 
hétérogènes et exercent des rôles distincts et essentiels dans l'immunité protectrice. 
Typiquement, les cellules effectrices mémoires sont capables de tuer immédiatement le 
pathogène tandis que les cellules centrales mémoires sont responsables d’initier une réponse 
immunitaire complète. Pourtant, les mécanismes biochimiques qui contrôlent les fonctions de 
ces cellules ont été jusqu'à présent peu étudiés à cause de la faible fréquence de ces cellules et de 
la quantité limitée de tissus humains disponibles pour les analyses. La compréhension de ces 
mécanismes est cruciale pour la réalisation de vaccins efficaces et pour le développement de 
nouveaux médicaments capables de moduler la réponse immunitaire lymphocytaire. Dans cette 
thèse, nous avons d'abord développé et amélioré une technologie appelée ‘protéine array en 
phase inverse’ qui possède un niveau de sensibilité beaucoup plus élevé par rapport aux 
technologies classiquement utilisées dans l’étude des protéines. Grâce à cette technique, nous 
avons pu comparer la composition protéique du système de transmission des signaux 
d’activation des cellules CM et EM humaines. L’analyse de 8 à 13 sujets sains a montré que ces 
populations des cellules mémoires possèdent un système de signalisation protéique différent. En 
effet, les cellules EM possèdent, par rapport aux cellules CM, des niveaux réduits d’une protéine 
régulatrice (appelée c-Cbl) que nous avons démontré comme étant responsable des fonctions 
spécifiques de ces cellules. En effet, en augmentant artificiellement l’expression de cette 
protéine régulatrice dans les cellules EM jusqu’au niveau de celui des cellules CM, nous avons 
induit dans les cellules EM des capacités fonctionnelles caractéristiques des cellules CM. En 
conclusion, notre étude a identifié, pour la première fois chez l’homme, un mécanisme 
biochimique qui contrôle les fonctions des populations des cellules mémoires. 
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Résumé en Français 
Les cellules mémoires persistent inertes dans l’organisme et produisent des réactions 
immunitaires rapides et robustes contre les pathogènes précédemment rencontrés. Deux 
populations distinctes des cellules mémoires ont été identifiées chez l'homme: les cellules 
centrales (CM) et effectrices (EM) mémoires. Ces populations sont fonctionnellement 
hétérogènes et exercent des rôles distincts et critiques dans l'immunité protectrice. Les 
mécanismes biochimiques qui contrôlent leurs fonctions ont été jusqu'à présent peu étudiés, 
bien que leur compréhension soit cruciale pour le développement des vaccins et des nouveaux 
traitements/médicaments. Les limites majeures à ces études sont la faible fréquence de ces 
populations et la quantité limitée de tissus humains disponibles. Dans cette thèse nous avons 
d'abord développé et amélioré la technologie de ‘protéine array en phase inverse’ afin 
d’analyser les molécules de signalisation des cellules mémoires CD4 et CD8 humaines isolées 
ex vivo. L’excellente sensibilité, la reproductibilité et la linéarité de la détection, ont permis de 
quantifier des variations d'expression protéiques supérieures à 20% dans un lysat équivalent à 
20 cellules. Ensuite, grâce à l'analyse de 8 à 13 sujets sains, nous avons prouvé que les cellules 
mémoires CD8 ont une composition homogène de leur système de signalisation tandis que les 
cellules CD4 EM expriment significativement de plus grandes quantités de SLP-76 et des 
niveaux réduits de c-Cbl, Syk, Fyn et LAT par rapport aux cellules CM. En outre, l'expression 
réduite du régulateur négatif c-Cbl est corrélée avec l'expression des SLP-76, PI3K et LAT 
uniquement dans les cellules EM. L’évaluation des propriétés fonctionnelles des cellules 
mémoires a permis de démontrer que l'expression réduite du c-Cbl dans les cellules EM est 
associé à une diminution de leur seuil d'activation. En effet, grâce a la technique de 
transduction cytosolique, nous avons augmenté la quantité de c-Cbl des cellules EM à un 
niveau comparable à celui des cellules CM et constaté une réduction de la capacité des 
cellules EM à proliférer et sécréter des cytokines. Ce mécanisme de régulation dépend 
principalement de l'activité d'ubiquitine ligase de c-Cbl comme démontré par l'impact réduit 
du mutant enzymatiquement déficient de c-Cbl sur les fonctions de cellules EM. En 
conclusion, cette thèse identifie c-Cbl comme un régulateur critique des réponses 
fonctionnelles des populations de cellules T mémoires et fournit, pour la première fois chez 
l'homme, un mécanisme contrôlant l'hétérogénéité fonctionnelle des ces cellules. De plus, elle 
valide l'utilisation combinée des ‘RPP arrays’ et de la transduction cytosolique comme outil 
puissant d’analyse quantitative et fonctionnel des protéines de signalisation. 
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 Summary 
Memory cells persist in a quiescent state in the body and mediate rapid and vigorous immune 
responses toward pathogens previously encountered. Two subsets of memory cells, namely 
central (CM) and effector (EM) memory cells, have been identified in humans. These subsets 
display high functional heterogeneity and assert critical and distinct roles in the control of 
protective immunity. The biochemical mechanisms controlling their functional properties 
remain so far poorly investigated, although their clarification is crucial for design of effective 
T-cell vaccine and drug development. Major limitations to these studies lie in the low 
frequency of memory T cell subsets and the limited amount of human specimen available. 
In this thesis we first implemented the innovative reverse phase protein array approach to 
profile 15 signalling components in human CD8 and CD4 memory T cells isolated ex vivo. 
The high degree of sensitivity, reproducibility and linearity achieved, allowed an excellent 
quantification of variations in protein expression higher than 20% in as few as 20-cell 
equivalent per spot. Based on the analysis of 8 to 13 healthy subjects, we showed that CD8 
memory cells have a homogeneous composition of their signaling machinery while CD4 EM 
cells express statistically significant increased amounts of SLP-76 and reduced levels of c-
Cbl, Syk, Fyn and LAT as compared to CM cells. Moreover, in EM but not CM cells, 
reduced expression of negative regulator c-Cbl correlated with the expression of SLP-76, 
PI3K and LAT. Subsequently, we demonstrated that the higher functional properties and the 
lower functional threshold of EM cells is associated with reduced expression of c-Cbl. 
Indeed, by increasing c-Cbl content of EM cells to the same level of CM cells using cytosolic 
transduction, we impaired their proliferation and cytokine production. This regulatory 
mechanism was primarily dependent on c-Cbl E3 ubiquitin ligase activity as evidenced by 
the weaker impact of enzymatically deficient c-Cbl C381A mutant on EM cell functions. 
Together, these results identify c-Cbl as a critical regulator of the functional responses of 
memory T cell subsets and provides, for the first time in humans, a mechanism controlling 
the functional heterogeneity of memory CD4 cells. Moreover it validates the combined use of 
RPP arrays and cytosolic transduction approaches as a powerful tool to quantitatively analyze 
signalling proteins and functionally assess their roles. 
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1. Memory T cells  
“…Yet it was with those who had recovered from the disease…  
       …for the same man was never attacked twice- never at least fatally…” 
(Thucydides, The Peloponnesian Wars) 
 
   Nearly 2500 years ago, the ancient Greek Thucydides noted that patients recovering from 
the plague of Athens did not contract it again (Retief and Cilliers 1998). That is what 
scientists call “Immunological Memory” or in other words, the fascinating capacity of our 
immune system to respond more rapidly and strongly to pathogens that were previously 
encountered. In 1846, the Danish physician Panum underlined in his study on measles 
epidemics on the Faeroe Islands how impressive could be the duration of immunological 
memory in humans. Indeed, survivors of the first epidemics in 1781 were still immune to a 
second epidemic that struck the island more than 65 years later (Panum 1939).  
Immunological memory is based on long-lived antigen-specific memory B and T 
lymphocytes that arise during primary infection, persist for decades and are able to elicit a 
robust immune response when the antigen is re-encountered (Fig.1).  
 
 
 
 
   The obvious application of this process is vaccination, a practice already common in China 
over 1000 years ago, but that took its name only by the late 1700 in honor of Edward Jenner 
who inoculated healthy subjects with cowpox exudates to protect them against antigenically 
related smallpox (Latin: cow = vacca) (Jenner 1798). Vaccination had an enormous impact on 
worldwide health, second only to the introduction of the modality of drinking clean water 
Fig.1 Immunological memory.  
Long-lived memory cells arising from the 
primary immune response rapidly and 
strongly react to antigen previously 
encountered generating a robust secondary 
immune response. 
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(Wolman 1975). Therefore, it appears evident how important is the understanding of the 
mechanisms at the basis of immunological memory. I will focus the following discussion on 
memory T lymphocytes since these cells were studied in this thesis. 
 
 
1.1 Generation of memory T cells 
1.1.1 Initiation of the immune response  
   Prior to contact with antigen, quiescent naïve T cells (cells that have never encountered their 
cognate antigen) continuously migrate from the blood, through secondary lymphoid tissues, to 
the lymphatic vessels that collect in the thoracic duct to empty back into the blood at the left 
subclavian vein. Continuous blood-to-lymph recirculation is highly important for allowing T 
cells to make rapid contact in the secondary lymphoid tissues with antigens released from 
pathogens. Indeed, antigens entering the body are carried in afferent lymph to draining lymph 
nodes or taken up by professional antigen presenting cells (APCs) such as peripheral dendritic 
cells (DCs), which are stimulated and migrate to lymph nodes by shifting their inflammatory 
chemokine receptors (e.g. CCR1 and CCR5) to lymphoid-homing receptors (e.g CCR7) 
(Sprent and Surh 2002). Antigens are processed to short peptides by DCs and presented on 
major histocompatibility complex (MHC) class I and class II molecules to initiate the 
response of CD8 and CD4 T cells, respectively. However, simple recognition of MHC-
peptide (p-MHC) by the T cell receptor (TCR) often produces tolerogenic responses 
(Goodnow 2001), and effective immune responses are only initiated in the presence of co-
stimuli. Most infectious microorganisms contain “adjuvants” such as lipopolisaccarides 
(LPS), lipoproteins, unmethylated CpG DNA, and double-stranded RNA, that are recognized 
by a spectrum of highly conserved Toll-like receptors (TLRs) expressed on cells of the innate 
immune system and promote their activation. As a consequence, activated DCs up-regulate 
co-stimulatory molecules for T cells, such as CD40, B7-1 and B7-2, (ligands for CD40L, 
CD28 and CTLA-4, respectively, on T cell). In addition, other cells of the innate immune 
system (macrophages, natural killer (NK), mast cells) produce stimulatory cytokines and 
chemokines favoring T cell activation (Pasare and Medzhitov 2004). 
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1.1.2 T cell clonal expansion and contraction phase 
   Naïve T cells continue blood-to-lymph recirculation until their TCR recognizes the 
appropriate foreign antigen-MHC complex carried by activated APCs draining from the site 
of infection in the T cell zone of a secondary lymphoid organ (lymph nodes, spleen and 
Peyer’s patches), resulting in T cell immobilization and activation. During the early phase of 
the response, rapid replication of the pathogen ensures large numbers of activated APCs into 
the T cell zone where responding T cells are stimulated to rapidly proliferate, synthesize 
cytokines and differentiate into effector T cells, i.e. cytotoxic and helper T cells (for CD8 and 
CD4 T cells respectively) (Sprent and Surh 2002). Both CD4 and CD8 T cells undergo an 
extensive clonal expansion, although CD4 T cell proliferation is slower and less pronounced 
than that of CD8 T cells (Homann, Teyton et al. 2001) (Fig.2).  
Within 1-2 weeks, the peak of the proliferative response is reached and T cells undergo a 
contraction phase. Indeed, at later stages of the response, pathogen clearance reduces inflow 
of activated APCs into the T cell zone, and T cell interaction with diminishing numbers of 
antigen-bearing APCs exhausts the capacity of APCs to produce stimulatory cytokines, thus 
resulting in reduced formation of effector cells. The rapid disappearance of effector cells at 
the end of the primary response appears to be regulated by homing to non-lymphoid tissues 
and apoptosis (Sprent and Surh 2002). Of interest, CD4 T cells show a biphasic pattern of 
contraction whereas CD8 T cells display massive and rapid collapse after expansion in 
primary cellular immune response to lymphocytic choriomeningitis virus (De Boer, Homann 
et al. 2003). However, after the loss of short-lived effector cells, a small proportion of T cells 
survive to become long-lived memory cells (Fig.2).  
 
 
 
Fig.2 Kinetics of T-cell responses.  
CD8 T-cell expansion and contraction is very rapid, 
so that memory is rapidly established. In contrast, 
CD4 T cells display a prolonged clonal biphasic 
contraction phase and memory is established only at 
later time point. (Beverley 2008) 
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1.2 Phenotypical and functional properties of memory T cells 
1.2.General properties 
Memory is the hallmark of the acquired immune system. Indeed memory cells confer 
protective immunity: they persist in a quiescent state and when reactivated by the cognate 
antigen mediate robust responses characterized by the rapid production of high levels of 
effector cytokines at low activation thresholds (Chandok and Farber 2004). Memory cells 
results from the differentiation of naïve cells during the primary immune response. However, 
how and at what stage of the immune response memory cells arise is still a matter of debate. It 
is possible that memory cells directly originate from cells undergoing an asymmetrical first 
division (Chang, Palanivel et al. 2007), or from cells that failed to differentiate towards 
effector cells following the initial contact with the APCs during primary response. However, 
evidence showing that precursors of memory cells undergo proliferation during primary 
response (Opferman, Ober et al. 1999; Rogers, Dubey et al. 2000) and, at least transiently, 
express effector functions (Jacob and Baltimore 1999; Opferman, Ober et al. 1999), supports 
the idea that memory cells might derive from effector cells (Sprent and Surh 2002). Of 
interest, clonal exhaustion caused from progressive shortening of telomere length is prevented 
in T lymphocytes during clonal expansion by up-regulation of telomerase (Maini, Soares et al. 
1999). Unlike B cells, naïve T cells do not undergo somatic hypermutation-based affinity 
maturation during the primary immune response. It is instead believed that optimization of 
cellular immunity is mediated almost exclusively through selective expansion of T cells 
bearing receptors with the highest affinity for antigen. As a result of differentiation, memory 
cells display an optimization of the signal transduction machinery as well as of the expression 
of adhesion and effector molecules (Slifka and Whitton 2001) with respect to naïve cells. In 
addition, memory cells show more extensive lipid rafts (Viola 2001) and display higher 
degree of chromatin decondensation, with constitutive expression of mRNA of some effector 
proteins (including INFγ, RANTES..) (Kaech, Hemby et al. 2002). Together, when stimulated 
by antigen, memory cells show a shorter lag time (compared to naïve cells) for entering cell 
cycle, synthesizing cytokines, differentiating in effector cells, and migrating to non-lymphoid 
tissues while being less dependent on co-stimulation (Rogers, Dubey et al. 2000; Sprent and 
Surh 2002). Consistently, memory cells are metabolically more active than naïve cells and 
show higher rate of turnover in vivo (Tough and Sprent 1995). Thus, the efficacy of memory 
cells in mounting a rapid and robust secondary response is a direct consequence of their 
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enhanced responsiveness to antigen, as well as their ability to reside within (or migrate to) 
peripheral tissues (Sprent and Surh 2002). In addition, the precursor frequency of antigen-
specific memory cells is far higher than for naïve cells, contributing to the generation of an 
intense immune response (Sprent and Surh 2002). Memory T cells therefore represent a 
highly effective and rapidly mobilizable “effector” system. As reported above, memory cells 
show distinct phenotypic differences (other than functional differences) from naïve cells, 
including alteration in the expression levels of adhesion (e.g. CD62Llo, CD44hi…) and 
activation molecules (e.g. CD45RA/B/Chi, CD122hi…) (Michie, McLean et al. 1992; Dutton, 
Bradley et al. 1998). 
 
1.2.2 Maintenance  
   Naïve and memory T lymphocyte numbers are maintained constant in adult to ensure that 
the organism can mount an immune response to a variety of new antigens, while keeping 
appropriate levels of memory cells to previously encountered pathogens. As immunological 
space is finite, naïve (N) and memory cells must be subject to homeostasis and competition 
for survival within the T cell pool (Beverley 2008). Both signalling from TCR and cytokines 
receptor have been implicated in the maintenance and homeostatic expansion of T cell pools, 
but their relative contribution may vary under different conditions.   
   Long-term survival of CD4 and CD8 N T cells requires a combination of signals arising 
from joint contact with self-peptide-MCH ligands and interleukin-7 (IL-7). Abrogation of 
either of these signals reduced the life-spam of N T cells (usually years) to around 2-4 weeks. 
In contrast, overexpression of IL-7 leads to expansion of N T cell pool in absence of antigen. 
Thus IL-7 appears to be the primary cytokine for maintaining survival of N T cells, and the 
basal level of IL-7 appears to determine the overall size of naïve T-cell pool. In CD8 cells this 
survival is mediated through sustained high levels of the anti-apoptotic protein Bcl-2 and is 
inhibited by TGF-β (Boyman, Purton et al. 2007). 
   Survival of memory T cells appears to be independent of signalling through TCR while 
being dependent on signals received by cytokines. Indeed, memory cells are able to survive 
not only in the absence of antigen (Mullbacher 1994) but also in the absence of MHC 
molecules (Swain, Hu et al. 1999) or after conditional TCR ablation (Polic, Kunkel et al. 
2001). Nonetheless, foreign antigens may play an indirect role through activation of the innate 
immune system or may provide an advantage in the competition for survival (Beverley 2008).  
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   CD8 memory T cells were shown to be dependent primarily on the cytokines IL-15 for 
homeostatic proliferation and survival, although IL-7 did contribute to their long-term 
persistence, particularly in a competitive environment (Surh, Boyman et al. 2006). Notably, 
the majority of memory CD8 T cells express high levels of CD122 (IL-2 receptor β chain (IL-
2Rβ) – common subunit for IL-2 and IL-15 receptor) and IL-7Rα.  Recent evidence proved 
that transcription factor T-bet and eomesodermin are crucial for maintaining high levels of 
CD122 (Intlekofer, Takemoto et al. 2005) in memory cells. 
Experiments with IL-15-/- mice demonstrated that IL-15 was not required for the generation of 
antigen-specific memory CD8 T cells, but was essential for their long-term survival (Becker, 
Wherry et al. 2002), as well as for maintenance of memory phenotype (MP) cells (Kennedy, 
Glaccum et al. 2000; Judge, Zhang et al. 2002). MP cells are spontaneously arising cells in 
normal animals that share many phenotypic and functional characteristic of antigen-specific 
memory cells (Sprent and Surh 2002). IL-15 probably supports survival of memory CD8 T 
cells by up-regulating anti-apoptotic molecules such as Bcl2 and Bcl-XL. The signalling 
pathways triggered by IL-15 appear to be transmitted through STAT5 activation and are 
negatively modulated by SOCS-1 (Davey, Starr et al. 2005). Under normal condition, the 
basal level of IL-15 is established by the constitutive production of IL-15 by DCs. However, 
IL-15 production is efficiently enhanced by interferons (IFNs), especially IFN-I, produced 
following activation of the innate immune system by viral infection or LPS injection (Tough, 
Sun et al. 1997). The reduced numbers of MP CD8 cells found in IFN-I receptor-deficient 
mice suggest that background production of IFNs determine the basal level of IL-15 
necessary for memory CD8 T cell maintenance. Apparently, the basal level of IL-15 (and 
IFNs) is induced solely through endogenous mechanism in the absence of signals from 
environmental or commensal antigens (Surh, Boyman et al. 2006). Despite the role of IL-15, 
other γc cytokines are known to affect memory CD8 T-cell homeostasis. In particular, 
increasing level of IL-7 can overcome the requirement for IL-15 in lymphopenic 
environment, as observed in IL-7 transgenic IL-15-/- mice that show increased number of MP 
CD8 T cells (Kieper, Tan et al. 2002). However, the level of IL-7 found in normal condition 
is probably too low to be used by memory cells while enough to support survival of N cells. 
The role of IL-2 in memory CD8 T cell survival is controversial. Injection of mAb that were 
thought to neutralize circulating IL-2 was causing a marked increase in basal homeostatic 
proliferation of MP CD8 T cells, underling a putative suppressing role for this cytokine (Ku, 
Murakami et al. 2000). However, it has been recently experimentally proved that anti IL-2 
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mAbs instead enhance the in vivo biological activity of pre-existing IL-2 on memory CD8 T 
cells (Boyman, Kovar et al. 2006).  
   The factors regulating homeostasis of memory CD4 T cells are less well understood than for 
memory CD8 T cells. CD4 memory cells were initially thought not requiring γc cytokines for 
survival, as CD4 memory cells deficient for CD132 (γc-chain) are effectively maintained in 
vivo (Lantz, Grandjean et al. 2000). However, subsequent studies revealed an essential role 
for IL-7 for survival of both MP and TCR transgenic CD4 memory cells (Li, Huston et al. 
2003; Seddon, Tomlinson et al. 2003). Not surprising, memory CD4 cells express high levels 
of CD127 (Interleukin 7 receptor α chain) but low levels of CD122 (common chain to IL2 
and IL15 receptor). Nonetheless, a long lasting boost in CD4 memory cells was observed 
following administration of IL-2 or IL-15 to rhesus macaques during the contraction phase 
following influenza virus (Villinger, Miller et al. 2004), underling a possible role for these 
cytokines in homeostasis of CD4 memory cells. The involvement of MHC ligands in memory 
CD4 cell homeostasis remains matter of debate. Recently, it has been proposed that signals 
from both TCR and cytokines (notably IL-7) could synergize to promote survival of CD4 
memory cells (Riou, Yassine-Diab et al. 2007). Finally, in contrast to CD8 cells, the 
molecular mechanism governing memory CD4 cell survival appear to be based on up-
regulation of Bcl-XL but not Bcl2 (Sprent and Surh 2002). 
 
1.2.3 Memory T cell subsets: central and effector memory cells  
1.2.3.1 Phenotypical and functional properties 
   Human memory T lymphocytes (defined as phosphatase CD45RA negative) comprise two 
main distinct populations, termed central memory (CM) and effector memory (EM) cells. 
They were delineated based on the expression of chemokine receptor CCR7 that defines their 
distinct functions and homing capacities (Sallusto, Lenig et al. 1999) 
   CM cells (CD45RA-, CCR7+) constitutively express at their surface CCR7 and CD62L. 
These two receptors are also expressed by N cells and are required for homing to secondary 
lymphoid organs. While having limited effector functions, CM cells have higher sensitivity to 
antigenic stimulation as compared to N cells, are less dependent on CD28 co-stimulation and 
show high proliferative capacity. Moreover, CM cells up-regulate CD40L, providing more 
effective stimulatory feedback to DCs and B cells, and at least in vitro, can differentiate to 
EM cells upon secondary stimulation (Sallusto, Lenig et al. 1999) 
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   EM cells (CD45RA-, CCR7-) lack the expression of CCR7, are heterogeneous for CD62L 
expression, and display adhesion molecules (e.g. high level of β1 and β2 integrins) and 
chemokine receptors (e.g. CCR1, CCR3, CCR5) that are required for homing to inflamed 
peripheral tissues. Compared to CM cells, EM cells display immediate effector functions 
(Sallusto, Geginat et al. 2004) and have an imprinted TH1, TH2 (for CD4 cells) or CTL (for 
CD8 cells) phenotype. Furthermore, in CD8 T cells, an additional subset lacking CCR7 and 
CD62L but keeping CD45RA expression has been identified. Since this subset displayed 
higher effector function, it was named “terminally differentiated” (Sallusto, Lenig et al. 
1999). 
   The memory subset distribution in the blood of healthy individuals varies between CD4 and 
CD8 compartment, with CM more frequent in CD4 cells and EM predominant in CD8 cells 
(Fig.3). Within the tissues, CM cells are enriched in secondary lymphoid organs (lymph node 
and tonsils) while EM cells traffic mainly to peripheral tissues (especially lung, liver, gut) 
(Campbell, Murphy et al. 2001).  
 
 
Fig.3 Memory T cell subset distribution.  
Phenotypes of CD4 and CD8 T cell memory subsets in the peripheral blood of a representative healthy donor 
based on the expression of the chemokine receptor CCR7 and the phosphatase CD45. N (naïve), CM (central 
memory), EM (effector memory) and E (terminally differentiated) cells are shown with the corresponding 
frequency.  
 
 
   The existence of two subsets of memory cells with distinct functions and migratory 
capacities suggest a subdivision of tasks among memory cells. On one hand, EM cells 
represent a readily available pool of antigen-primed cells which can enter peripheral tissues 
and can give immediate protection. On the other hand, CM cells represent a “stem cell-like” 
pool of antigen-primed cells, which traffic through secondary lymphoid organs and, upon 
secondary challenge, can rapidly and efficiently generate a new wave of effector cells.  
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   Using in vivo labeling with with deuterated glucose, it was shown that human CD4 EM cells 
have a proliferation rate of 4.7% per day compared to 1.5% of CM and only 0.2% of N cells. 
Thus, human memory subsets, and in particularly EM cells, constitute short-lived cell 
populations (average intermitotic times of 15 and 48 days for EM and CM, respectively) that 
require continuous replenishment in vivo (Macallan, Wallace et al. 2004). 
   When activated in vitro both memory subsets show low-activation threshold and vigorous 
proliferation. However, the expansion potential decreases from CM to EM cells, with a 
corresponding decrease in telomere length (Sallusto, Lenig et al. 1999; Geginat, Sallusto et al. 
2003). Moreover, CD4 CM cells stimulated in vitro appear heterogeneous in their ability to 
differentiate: some cells appear uncommitted and can be induced to differentiate to T helper 1 
(TH1, which mainly secrete IFNγ/TNF and lead to cell-mediated immunity) and T helper 2 
(TH2, which mainly secrete IL-4, IL-5, IL-6 and promote humoral immunity) by IL12 and IL4 
stimulation, respectively. Other cells spontaneously differentiate to INF-γ or IL-4 producing 
cells, representing pre-TH1 and pre-TH2 cells (defined by CXCR3 and CCR4 expression, 
respectively) (Sallusto, Geginat et al. 2004). 
   In contrast to CM cells, EM cells stimulated under non-polarizing conditions, retain their 
TH1 and TH2 imprinted phenotype. However, when stimulated under opposite polarizing 
conditions, EM cells acquire in addition the ability to secrete the alternative cytokines 
(Sallusto, Geginat et al. 2004). Of interest, upon antigenic stimulation, CM cells loose the 
expression of CCR7 whereas EM cells, following a rapid and transient CCR7 upregulation, 
maintain their CCR7- phenotype (Sallusto, Geginat et al. 2004). 
1.2.3.2 Generation  
   While the heterogeneity in humans of memory T cells is now well accepted, the signals 
regulating the generation of the different populations are not fully understood. However, 
increasing evidence (Lanzavecchia and Sallusto 2002; Gett, Sallusto et al. 2003; Sallusto, 
Geginat et al. 2004; Stemberger, Neuenhahn et al. 2007; Kalia, Sarkar et al. 2008) suggests 
that the strength and the quality of the signals delivered by TCR and cytokine receptors drive 
CD4 and CD8 naive T cells through hierarchical thresholds of differentiation and lead to the 
generation of effector as well as memory populations. Thus, in increasing order of strength of 
stimulation, the fate of a naïve T cell range from unfit cells that undergo abortive 
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differentiation or apoptosis, to fit cells that give rise to CM, EM and terminal differentiated 
cells (progressive differentiation model, proposed by Lanzavecchia and co-workers) (Fig.4).  
Alternatively, studies on mouse CD8 T cells proposed that memory cells could directly origin 
from effector cells. According to this model, EM cells are a transitory population representing 
an intermediate cell type in the effector to memory transition that, in the absence of antigen, 
convert directly to CM cells (linear differentiation model, proposed by Ahmed and 
coworkers) (Wherry, Teichgraber et al. 2003). Finally, another model based on the idea that 
CM and EM cells are independent population has been recently proposed (Baron, Bouneaud 
et al. 2003). 
 
 
 
Fig.4 Signal strength model of memory T cell generation.  
The duration and intensity of antigenic stimulation is indicated by the length and thickness of the solid arrows. 
Antigen-independent events leading to T cell proliferation and differentiation are indicated by the dotted lines. 
AICD, activation-induced cell death. (Adapted from Gett, Sallusto et al. 2003) 
 
1.2.3.3 Gene expression profile 
   Despite these phenotypical and functional differences, only few studies have conducted 
comparative gene expression profiling of human memory CD4 (Liu, Li et al. 2001; Riou, 
Yassine-Diab et al. 2007) and CD8 T cells (Willinger, Freeman et al. 2005). Few differences 
were reported in gene expression between N and memory CD4 T cells (Liu, Li et al. 2001), 
while analysis of CD8 T cells revealed a clear dichotomy between CM and EM cells. 
However, a very small number of truly CM- and EM-specific genes were identified in spite of 
the fact that CM cells possess a gene transcription signature intermediate between that of N 
and effector (E) cells (Willinger, Freeman et al. 2005). More recently CD4 CM cells 
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(CD45RA-, CCR7+, CD27+) have been reported to express lower levels of proapoptotic and 
cell cycle-related genes described as FOXO3a target genes, relative to their EM counterparts. 
The convergence of TCR and cytokine-induced signals causes FOXO3a phosphorylation and 
seems to drive the survival of CM cells (Riou, Yassine-Diab et al. 2007). Moreover, both 
CD4 and CD8 CM cells display a high basal and induced STAT5 phosphorylation in response 
to IL-2-related cytokines (Willinger, Freeman et al. 2005; Riou, Yassine-Diab et al. 2007). 
 
 
1.3 Memory T cell subsets and vaccines 
   Most currently successful vaccines induce antibody responses against antigenically stable 
pathogens that cause lytic or acute infection (Hilleman 2000). However, many chronic 
diseases such as malaria, human immunodeficiency virus (HIV) and hepatitis C virus (HCV) 
require strong cellular immune response for pathogen control or elimination. The recognition 
of this aspect has recently encouraged many researchers to develop vaccine strategies able to 
induce an effective cell-mediated immunity. CM and EM T cells play different roles in the 
control of viral diseases (Appay, Dunbar et al. 2002; Harari, Vallelian et al. 2004) (Peretz, 
Ndongala et al. 2007; Mason, De Rose et al. 2008). In mice, CM T cells are more efficient in 
conferring disease protection (Wherry, Teichgraber et al. 2003; Castiglioni, Gerloni et al. 
2004; Zaph, Uzonna et al. 2004). Moreover, murine (Lauvau, Vijh et al. 2001; Seaman, 
Peyerl et al. 2004) and macaque (Vaccari, Trindade et al. 2005) models of vaccination suggest 
that the type of memory T cells elicited is a key element for the clinical effectiveness of the 
vaccine. Of interest, in a model of SIV infection in rhesus macaque, vaccine-induced 
protection correlated with expansion of CM but not EM CD8 T cells (Vaccari, Trindade et al. 
2005). Therefore, defining the different types of memory T cells and determining which 
subset correlates with protective immunity is a basis for rational design of effective T-cell 
vaccines. Recently, it has been shown that the levels of viral load correlates with distinct 
functional signatures of T-cell responses (Pantaleo and Harari 2006). In particular, antiviral 
protective immunity in chronic virus infections is characterized by a polyfunctional (IL-2 and 
IFN-γ secretion and proliferation) but not monofunctional signature (Harari, Dutoit et al. 
2006). Therefore, the ability of a T-cell vaccine to induce polyfunctional T-cell responses 
may be an important parameter for its evaluation and immunological improvement. 
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2. Immunobiology of the T Cell Receptor (TCR) 
2.1 History and discovery of the TCR 
   March 8, 1984. This date marked the end of a long and frustrating search and the beginning 
of a new chapter in immunology: two Nature back-to-back articles finally described the genes 
encoding the β-chains of the human and mouse TCR (Hedrick, Cohen et al. 1984; Yanagi, 
Yoshikai et al. 1984). Since that date, more that 30000 scientific papers have been published 
on TCR-related subjects and many questions that accumulated in the two decades prior this 
discovery could be answered. As far back as the 1960s, it was clear that the functions of T 
lymphocytes were important for immunity. However, it was largely unclear how these cells 
recognize and respond to non-self antigens. It proved to be much more difficult to define the 
moleculare nature of the TCR than that of the B cell receptor (BCR) (Mak 2007). Indeed, the 
Ig proteins that function as antigen recognition component of the BCR are not only expressed 
on the B cell surface but are also secreted in large quantities as antibodies. The latter were 
already familiar to immunologists before the characterization of the BCR (Porter 1963). This 
information, coupled with the fact that B cells contain large amount of mRNA encoding Ig 
proteins (5% of total mRNA), paved the way for the cloning of the genes encoding the BCR 
and the discovery of Ig gene rearrangement (Hozumi and Tonegawa 1976). In contrast, as 
TCRs are not secreted like antibodies, it was difficult to purify sufficient protein for gene 
cloning and structural analysis. In addition, many researchers believed that TCR recognized 
antigen in much the same way as B cells did and therefore they unsuccessfully devoted a great 
deal of time to prove this. Between 1960 and 1983, immunologists concentrated their efforts 
in establishing reagents able to unambiguously identify and characterize TCR proteins. 
Unfortunately, these intense efforts went largely un-rewarded. Finally, in 1982, Allison and 
colleagues generated a mAb recognizing a particular structure on mouse T cell lymphoma 
cells which had the unusual property of being clone-specific (Allison, McIntyre et al. 1982). 
Within a year, other laboratories succeed in isolating mAbs with similar properties. The 
clone-specific structures recognized by the different mAbs were thought to be the TCR. 
Biochemical analysis of these surface structures revealed heterodimeric proteins of about 45-
50 KDa that were composed of a α and a β chain (Acuto, Hussey et al. 1983; Kappler, Kubo 
et al. 1983). The cloning of the genes encoding the putative TCR β-chain both in human and 
mouse was accomplished one year later by applying a differential hybridization approach 
designed to isolate cDNA that were specific for T cells and not expressed in the related B 
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cells (Hedrick, Cohen et al. 1984; Yanagi, Yoshikai et al. 1984). Within one year the α-chain 
was also cloned and the complete structure of TCR was revealed (Chien, Becker et al. 1984; 
Yanagi, Chan et al. 1985). 
 
 
2.2 Structure of the TCR 
   The TCR delivers signals that are crucial both for T cell development in the thymus and 
antigen-induced cell activation in the periphery. In its smaller form, it is a genetically 
recombined receptor, similar to a Fab antibody fragment, and it is composed of two 
disulphide-bonded chains: either α and β chains in αβ T cells or γ and δ chains in γδ Τ cells. 
αβ TCRs are expressed by most T cells (>95% in adult donor (Lanier, Ruitenberg et al. 
1988)) and typically detect antigens presented on the surface of APCs in the context of 
appropriate MHC proteins (Fig.5A). A small subset of T cells, that I will not further describe, 
express γδ ΤCRs which bind directly to pathogen-derived glycoproteins or non-classical 
MHC molecules (Adams, Chien et al. 2005). Each polypeptide chain of the heterodimers is, 
for the most part, exposed to the extracellular side of the membrane (variable and constant 
domains), with a transmembrane domain located toward the C terminus and a short 
cytoplasmic tail of 2-7 amino acids (Bentley and Mariuzza 1996). The constant domain of the 
β chain adopts a standard Ig fold (sandwich like structure formed by two disulphide-bonded 
antiparallel β-sheets) (Adams, Chien et al. 2005), while that of the α chain adopts an atypical 
Ig fold due to the absence of a top β sheet. Clonotypically rearranged variable (V), diversity 
(D), and joining (J) gene segments encode the variable domain which is responsible for 
antigen recognition. The p-MHC binding site is comprised of six loops at the end of the 
variable domain called complementarity-determining regions (CDRs), with each chain 
contributing with three loops, named CDR1, CDR2 and CDR3. The CDR1 and CDR2 loop 
sequences are referred as “germline derived” because they are constant for each type of chain, 
whereas the CD3 loops vary and largely dictate the specificity for the peptide (Garcia and 
Adams 2005) (Fig5B).  
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Fig.5 High resolution crystal structure of αβTCR-pMHC-I complex.  
(A) TCR–pMHC-I complex (PDB accession code 1MI5). MHC, grey; peptide, magenta; TCR α- and β-chain, 
purple and cyan respectively. (B) Diagram highlighting the CDR loops in αβTCR-pMHC-I complex. The CDR 
loops are colored as follows: Vα CDR1, green; Vα CDR2, red; Vα CDR3, blue; Vβ CDR1, magenta; Vβ 
CDR2, orange; Vβ CDR3, cyan. The view is along the peptide-binding groove. (Stewart-Jones, McMichael et al. 
2003). 
 
 
   The TCR itself lacks a significant intracellular domain and is coupled to downstream 
signalling via association with CD3 molecules. Indeed, at the cell surface, αβ TCR is non-
covalently associated with the CD3δε, CD3γε, and CD3ζζ dimers (Wegener, Hou et al. 1995; 
Call and Wucherpfennig 2007). The extracellular domains of the CD3δε and CD3γε 
heterodimers consists of side-by-side paired Ig folds, whereas those of the CD3ζζ homodimer 
are only nine residues long and are unstructured. In contrast to the long connecting peptides 
of the TCR chains (19-26 aa), CD3 heterodimers have short conserved cysteine-rich 
(RxCxxCxE) stalk regions (Sun, Kim et al. 2004). The intracellular domain of the CD3 
δ, ε and γ chains contains a single immunoreceptor tyrosine-based activation motif (ITAM), 
while CD3ζ possesses a longer intracellular domain holding 3 ITAMs (Love and Shores 
2000) (Fig.6).  
   The association of each of the three dimeric signalling modules with the TCR is based on 
specific interactions between two conserved acid residues in their transmenbrane domains and 
one basic residue on one of the TCR chains (Fig.6) (Call, Pyrdol et al. 2002). The mutation of 
any one of these residues to alanine abrogates formation of the TCR/CD3 complex (Kearse, 
Roberts et al. 1995; Call and Wucherpfennig 2004). 
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Fig.6 Organization of the TCR–CD3 complex.  
The T-cell receptor (TCR) αβ heterodimer recognizes peptides in the context of MHC proteins and signals 
through the non-covalently associated CD3δε, CD3γε and ζζ dimers. (A) The association of each of the CD3 
dimeric signalling modules with the TCR is dependent on a specific basic residue (shown in blue) in the TCR 
transmembrane domains and a pair of acidic residues (shown in orange) in the transmembrane domains of the 
respective signalling module. (B) A projection of the three-dimensional TCR–CD3 assembly illustration is 
shown in two dimensions. Each circle represents the view down the axis of the respective transmembrane helix 
projecting into the membrane. (Call and Wucherpfennig 2004). 
 
 
   Assembly of a single copy of TCR heterodimer (that carries only 3 positive charges versus 
6 negative ones in the CD3 dimers) produces a potential charge imbalance in the TCR/CD3 
complex. Starting from this considerations, investigators proposed two models for TCR/CD3 
complex: the first holding a stoichiometry of 1:1:1:1 ratio of 
TCRαβ:CD3δε:CD3γε:CD3ζζ (Kearse, Roberts et al. 1995; Call, Pyrdol et al. 2002), the 
second proposing that 2 or more TCR heterodimers are present per complex to balance the 
charges (San Jose, Sahuquillo et al. 1998; Fernandez-Miguel, Alarcon et al. 1999). Using 
immunogold labeling and electron microscopy, Alarcon and colleagues observed co-existence 
of monovalent and multivalent forms of TCR at the cell membrane of resting T cells 
(Schamel, Arechaga et al. 2005). Currently, it is widely accepted that monovalent complexes 
are composed of 1:1:1:1 ratio between their subunits. However, it remains unknown if the 
multivalent receptor clusters are multimers of the monovalent form or contain different ratio 
between the individual subunits (Alarcon, Swamy et al. 2006).  
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   In αβ TCR, the assembly of the CD3 heterodimers with the receptor is based on similar 
electrostatic interaction, however, the CD3δε dimer associates strictly with TCRα and 
CD3γε with TCRβ. This specificity is most likely dictated by the extracellular regions of the 
different subunits rather than their transmembrane domains (Wegener, Hou et al. 1995; Call, 
Pyrdol et al. 2002). Xu et al. identified the TCR contact point for the conserved stalk region 
of the CD3δε subunits to be most probably the connecting peptides of the TCRα chain. 
Indeed, truncation of the TCRα immunoglobulin domains had no effect on assembly, whereas 
shortening of the TCRα connecting peptide significantly reduced CD3δε  association (Xu, 
Call et al. 2006). Moreover, interaction of CD3δε with the αβ TCR enables the subsequent 
association of CD3γε dimers, although the molecular mechanisms are still unclear (Call, 
Pyrdol et al. 2002). Finally, point mutations (Bolliger, Johansson et al. 1997) or artificially 
enlongation (Minguet, Swamy et al. 2008) of the membrane-proximal nine amino-acid 
extracellular domain of CD3ζζ  have been shown to impair TCR/CD3ζζ assembly.  
 
 
2.3 Activation and Signalling 
2.3.1 MHC peptide-TCR interaction  
   TCR paradoxically shows high sensitivity and specificity, while having a low affinity for its 
ligand (Karjalainen 1994). Increasing evidence shows that T cells can be activated by as few 
as 1–10 antigenic p-MHCs among a huge number of self-pMHCs on APCs (Irvine, Purbhoo 
et al. 2002). In addition, T cells exhibit an unsaturated response to a large range of p-MHC 
concentrations (up to 103-106 fold) (Alarcon, Swamy et al. 2006). Experimental (Schamel, 
Arechaga et al. 2005) and computational (Schamel, Risueno et al. 2006) evidence supports a 
recently proposed model, in which the multivalent TCRs are important for the detection of 
low-antigen concentrations, therefore conferring sensitivity, whereas the co-expressed 
monovalent TCRs could be responsible for dose-response effects at antigen concentrations 
that would saturate multivalent TCRs (Alarcon, Swamy et al. 2006). The model 
accommodates also recent finding suggesting that combination of antigenic p-MHC/self p-
MHC could modulate the sensitivity of T cell activation (Krogsgaard, Li et al. 2005).  
   During antigen recognition, the co-receptor molecules CD4 or CD8 associate on the T cell 
surface with the TCR (either directly or indirectly via CD3 molecules), and bind invariant 
sites on antigen-loaded MHC class II or MCH class I molecules on the APC, respectively 
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(Gao, Rao et al. 2002). The binding of co-receptor to the cognate MHC molecule is thought to 
stabilize the p-MHC-TCR interaction and to bring the kinase Lck (physically associated to the 
cytoplasmic tail of the co-receptor) in contact with the TCR to initiate phosphorylation events 
(Zamoyska 1998). Therefore, co-receptor binding greatly increases the sensitivity of a T cell 
to antigenic peptide presented on the MHC molecule. However, activation of CD4 T cells is 
dependent on the co-receptor engagement only at low antigen density whereas CD8 T cell 
activation depends on co-receptor engagements regardless of antigen density (Krogsgaard, 
Juang et al. 2007) 
 
2.3.2 From TCR ligation to intracellular signal propagation 
   The immediate outcome of TCR ligation by appropriate p-MHC complex is a rapid increase 
in phosphorylation of ITAMs in the CD3 subunits, leading to the initiation of the signalling 
cascade. How these events are generated as a consequence of TCR ligation remains partly 
understood. Multiple models have been put forward, including TCR clustering, co-receptor 
(CD4/CD8) recruitment and/or conformational changes as possible mechanisms (Kuhns, 
Davis et al. 2006; Krogsgaard, Juang et al. 2007). Structural comparisons between p-MHC 
bound and free soluble αβ TCRs have not revealed conformational changes that propagate 
further than the interface with p-MHC (particularly at CDR3 loop) (Rudolph, Stanfield et al. 
2006). Nevertheless, TCR ligation induces a conformational change in the cytoplasmic tails 
of CD3ε that results in exposure of a prolin-rich sequence able to recruit the adaptor protein 
Nck independently from protein tyrosine kinase (PTK) activation (Gil, Schamel et al. 2002). 
In addition, upon TCR/CD3 triggering the cytoplasmic tail of CD3ζ undergoes a 
conformational change from a lipid-bound helical structure to an unfolded structure (Aivazian 
and Stern 2000). Recently, it has been demonstrated that full activation of the TCR requires 
both clustering and conformational changes at the CD3ε subunit (Minguet, Swamy et al. 
2007).  
 
2.3.3 Intracellular TCR signalling  
   The sequence of intracellular signalling events coupled to TCR triggering has been 
elucidated by studies of T cell lines, clones and mouse knockout models. In the simplest 
sense, TCR signalling proceeds from the cytoplasm to the nucleus via a series of 
phosphorylation events that culminate in the activation of transcription factors and 
reorganization of the cytoskeleton. From a functional side, TCR signalling is a complex 
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dynamic event that can elicit a variety of T-cell responses (from immune response to 
unresponsiveness) depending on the cell subsets, the strength of TCR engagement by specific 
p-MHC ligand and the co-stimulatory/accessory molecules presented by the APC at the 
immunological synapse in vivo. According to the two-signal hypothesis model for 
lymphocyte activation proposed in the middle 1970s (Lafferty and Cunningham 1975), 
delivering of antigen-specific “signal 1” alone (TCR) promotes tolerance whereas 
development of an effective immune response requires the presence of an additional “signal 
2” derived from a co-stimulatory factor (e.g. CD28). Because of the complexity of the TCR 
signalling networks, I will simplify the following discussion by emphasizing the general 
architecture of the signalling and the few known events belonging to a differential signalling 
pathway in memory cells. Indeed, the role of many specific signalling molecules, such as Lck, 
ZAP-70, SLP-76, LAT and ERK, in memory T cell function in vivo has been difficult to 
establish due to the lack of peripheral T cells in the corresponding knockout (KO) mice 
(Straus and Weiss 1992; Negishi, Motoyama et al. 1995; Clements, Yang et al. 1998; Zhang, 
Sommers et al. 1999). 
2.3.3.1 Proximal events 
   A key initiating event in TCR signalling is tyrosine phosphorylation of the consensus 
sequence (D/E)xxYxxL(x)6-8YxxL present in the ITAMs of the CD3 subunits by the Src 
kinase Lck and Fyn. This leads to recruitment of the cytosolic tyrosine kinases Syk and ZAP-
70 through their tandem SH2 domains to the CD3 subunits (Kane, Lin et al. 2000) (Fig.7). 
ITAMs appear as a single copy on the CD3γ, δ, and ε chains and as a triplicate repeats on the 
ζ chains, thus each TCR complex contributes 10 ITAM motifs (Love and Shores 2000). 
While the precise mechanism of Src kinase activation remains unknown, the critical role of 
CD45 tyrosine phosphatase in CD4 cells is well established. Indeed, CD45 participates in a 
multimeric complex with the CD4 co-receptor (which is physically associated with Lck) and 
promotes the removal of the inhibitory C-terminal tyrosine phosphate residue of Lck (Y505), 
leading to a conformational change and activation. This conformational change also frees up 
the autologous SH2 domain, allowing Lck to interact with new partners (Weil and Veillette 
1994). CD45 exists in multiple alternatively spliced isoforms (CD45RO in memory cells; 
CD45RA and CD45RB in naïve and effector cells of human and mice, respectively) that 
differentially associate with TCR and/or co-receptor molecule. In mice CD45RO-TCR 
association is able to more efficiently promote Ras activation than CD45RA-TCR (Czyzyk, 
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Leitenberg et al. 2000). In humans, CD45RA is used to delineate memory T cells, although 
the correlation between CD45 isoforms and their functions remains yet unknown. After its 
docking to ITAM motifs, ZAP-70 is phosphorylated by Lck and therefore activated. In 
addition, Lck interacts directly with ZAP-70 through binding of its SH2 domain to the ZAP-
70 pY319 residue, leading to recruitment of additional ZAP-70 molecules and Lck substrates, 
such as the Tec kinase Itk (Pelosi, Di Bartolo et al. 1999). The stoichiometry of ITAM 
phosphorylation and the number of ZAP-70 molecules recruited is dictated by the affinity of 
the TCR for its peptide ligand (Madrenas, Wange et al. 1995).  
   Both ZAP-70 and Lck are essential for T cell development and activation (Straus and Weiss 
1992; Negishi, Motoyama et al. 1995). However some evidence suggests that memory and 
effector cells may undergo different signalling events at this proximal level. Indeed, increased 
expression of Fyn (Guillaume, Tuosto et al. 2003) and membrane and co-receptor associated 
Lck in mouse memory and effector CD8 T cells differentiated in vitro (Bachmann, Gallimore 
et al. 1999) have been associated with a decreased activation threshold. With respect to naive 
cells, human (Hall, Heffernan et al. 1999) and mouse (Farber, Acuto et al. 1997) memory 
CD4 T cells display reduced ZAP-70 tyrosine phosphorylation following TCR-stimulation, 
although CD3ζ is equally phosphorylated in both cell subsets (Farber, Acuto et al. 1997). In 
mice, this reduced ZAP-70 phosphorylation is coincident with reduced phosphorylation of 
downstream linker/adaptor molecules, such as SLP76 (Hussain, Anderson et al. 2002). In 
mice, ligation of MHC class II and of CD4 was reported to inhibit memory CD4 cell 
activation (Farber, Luqman et al. 1995). Moreover, human CD4 effector T cells differentiated 
in vitro reorganize their TCR signalling machinery by up-regulating the expression of FcRγ 
protein that belong to an altered TCR/CD3 signalling complex lacking CD3ζ. The 
TCR/CD3ε/FcRγ complex recruits and activates the Syk kinase in place of ZAP-70 
(Krishnan, Warke et al. 2003). Since ZAP-70, but not Syk, can trigger apoptosis in T cell 
(Zhong, Wu et al. 2004), preferential use of Syk may be a mechanism to promote human 
effector T cell survival. Finding of FcRγ/Syk+ T cells in the peripheral blood of systemic 
lupus erythematosus (autoimmune disease SLE) patients suggest that this proximal switch can 
occur also in vivo (Krishnan, Farber et al. 2003). 
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Fig.7 Schematic representation of TCR signalling pathways.  
TCR engagement by p-MHC and co-stimulatory molecules (CD28) results in T cell activation and 
differentiation.  Activation of MAP Kinases and Ca2+ signalling leading to nuclear translocation and 
mobilization of transcription factors NFAT, AP1 (Fos/Jun) and NF-κB are shown. 
 
2.3.3.2 Adaptor coupling and distal signalling events 
The direct substrates of ZAP-70 kinase are two critical adaptor proteins: linker for activated T 
cells (LAT) and SH2 domain-containing leukocyte protein of 76 KDa (SLP-76) (Chandok 
and Farber 2004). While lacking intrinsic enzymatic activity, these molecules function as 
molecular connection between proximal and distal signalling events by recruiting additional 
proteins to the signalling complex (Fig.7). Although LAT carries a transmembrane domain 
sufficient for membrane localization, palmitoylation at C26 and C29 is necessary for its 
efficient partitioning into glycolipid-enriched microdomains (GEMs, lipid raft) and for its 
tyrosine phosphorylation (Zhang, Sloan-Lancaster et al. 1998). When phosphorylated by 
ZAP-70, the 9 tyrosine-based motifs of LAT serve as docking sites for specific SH2-domain 
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containing proteins, including PLC-γI, Grb2, PI3 Kinase and Gads (Wange 2000). Moreover, 
through the interposition of the adaptor Gads, LAT recruits and stabilizes SLP-76 binding to 
the signalling complex (Nel 2002). SLP-76 recruits additional signalling molecules that bind 
to distinct structural regions: the N-terminal phosphorylated tyrosine-based motifs binds the 
guanine-exchange factor Vav, the proline rich region recruits the SH3 of Gads and the SH2 
domain binds to phosphorylated tyrosines of other adaptor proteins such as ADAP that 
promotes integrin-mediated T cell adhesion to APC (Chandok and Farber 2004; Burbach, 
Medeiros et al. 2007). The signalling complex resulting from these interactions represents a 
molecular crossroad from where key TCR signalling pathways arise, leading to intracellular 
Ca2+ mobilization, activation of MAPK cascades (ERK1/2, p38 and JNK), as well as 
cytoskeleton reorganization. 
 
   PLC-γI tyrosine phosphorylation is one of the major determinants for Ca2+ signalling. As 
mentioned above, PLC-γI SH2 domain is recruited to LAT at the vicinity of the cell surface 
membrane (Wange 2000). SLP-76, which is bound via Gads to LAT, recruits a Tec kinase, 
Itk, which ultimately phosphorylates PLC-γI leading to its catalytic activation and cleavage of 
phosphatidyl inositol-4,5 bisphosphate (PI-4,5-P2). The resulting cleavage products, IP3 and 
DAG, are responsible, respectively, for sustained elevation of [Ca2+]I (which promotes NFAT 
translocation to the nucleus via calcineurin activation) and activation of PKCθ (which is 
mainly involved in activation of NF-κB pathways) (Nel 2002). 
   The formation of the signalling complex is also crucial for MAPK activation. Through the 
interposition of Grb2, LAT can indirectly recruit to the cell membrane the guanidine 
exchange factor Sos, which promotes the transition of Ras to his active GTP-bound form. 
Once activated, Ras interacts and activates the serine-threonine kinase Raf-1, leading to the 
activation of the ERK cascade. Ultimately, ERK plays an essential role in the expression of 
transcription factors c-Fos and c-Myc (Nel 2002). 
   TCR engagement also leads to the activation of PI3K, that gets recruited to the signalling 
complex by directly binding LAT or indirectly binding the TCR via the phosphorylated 
adaptor TRIM. PI3K is comprised of a regulatory (p85) and a catalytic (p110) subunits and 
serves to anchor PLC-γI, Tec and Vav proteins to the plasma membrane (Blomberg, Baraldi 
et al. 1999). Of interest Vav, which is also recruited via SLP-76, is a guanidine exchange 
factor for Rac-1/Cdc42, which ultimately plays a crucial role in cytoskeleton reorganization 
as well as in activation of the JNK/p38 cascade, leading to expression of Jun and Fos 
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transcription factors, respectively. (Crespo, Schuebel et al. 1997; Acuto and Cantrell 2000). 
PI3K is also responsible for the recruitment and activation of the serine-threonine kinase Akt, 
which has critical role for promoting cell survival (Alessi and Cohen 1998). Moreover, PI3K 
is involved in CD28 signalling (see INTRODUCTION section 2.3.4), underlying a possible 
role in setting the threshold for T cell activation and differentiation (Michel, Attal-Bonnefoy 
et al. 2001).  
 
   Together, the sequence of signalling events coupled to TCR engagement results in the 
combined and regulated activation of MAP Kinases and Ca2+ signalling, leading to nuclear 
translocation and mobilization of transcription factors NFAT, AP1 (Fos/Jun) and NF-κB as 
exemplified by IL-2 gene transcription (Fig.8) (Northrop, Ho et al. 1994; Nel 2002). The type 
of MAP kinase activated during T cell stimulation may have a key role in driving effector and 
memory T cell differentiation and functions. For instance, p38 MAPK cascade regulates IFN-
γ gene expression in TH1 cells, but does not affect TH2 cytokines (Rincon, Conze et al. 2000). 
Furthermore, it has been shown that JNK, ERK and p38 MAP kinase may differentially 
couple to apoptosis or survival (Xia, Dickens et al. 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.8 Signalling cascade leading to IL-2 gene 
transcription. Synergistic activation of IL-2 promoter 
by Ca2+/cacineurin, Ras/MAP, and NF-κB cascades. 
The CD28 response element (CD28R) is a 
combinatorial element that requires activation of both 
the NF-κB and JNK cascade. Both cascades are 
dependent on CD28 costimulation. (Nel 2002) 
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2.3.4 CD28-mediated co-stimulation of TCR signalling 
   The membrane receptor CD28 is expressed on T cells at 3-fold higher frequency than the 
TCR and asserts key roles in enhancing TCR-mediated T cell activation. The ligands for 
CD28 are the structurally homologous proteins B7.1 (CD80) and B7.2 (CD86), which are 
expressed at high levels on activated professional APCs. The importance of the signals 
delivered by CD28-ligand interaction in T cell activation is underlined by the phenotype of 
both CD28- and CD80/CD86-deficient mice that display marked impairment of T cell 
responses (Lenschow, Walunas et al. 1996; Sharpe and Freeman 2002). However, CD28 
triggering alone results in the transient expression of only few genes (Diehn, Alizadeh et al. 
2002) and has no obvious biological consequences. Indeed, CD28-mediated signals are 
integrated with those that are induced by the TCR at a membrane proximal level and 
quantitatively act on TCR signalling networks enabling functional threshold to be overcome 
(Acuto and Michel 2003).  
   Of note, the cytoplasmic tail of CD28 contains 4 phosphorylated tyrosines and 2 proline-
rich motifs that are involved in PI3K, Grb2 binding as well as Lck, Itk and Vav1 activation 
(Nel 2002). CD28-mediated activation of PI3K involves activation of AKT by upstream 
PDK1. Activation of AKT links CD28 to two crucial pathways for controlling gene 
transcription during activation. Indeed, AKT cooperation with the TCR-induced activation of 
PKCθ promotes formation of active NF-kB and AKT-induced activation of GSK3α/GSK3β 
inhibits the nuclear export of NFAT. CD28 triggering induces also the activation of Itk and 
Tec kinases through binding via its proline-rich regions. These kinases are positive regulators 
of PLCγI pathways (increasing iCa2+, DAG-mediated activation of PKC, RAS/RAF/ERK 
activation through RASGRP activation) and appears to regulate WASP, a CDC42 activated 
protein involved in actin-cytoskeleton reorganization (Acuto and Michel 2003). Vav1 
phosphorylation also results from CD28 triggering, although the mechanism regulating 
CD28-mediated recruitment of Vav1 to the membrane remains unclear. CD28-activated Vav1 
affect many TCR signalling pathways (NFAT, NF-kB, AP1 as well as cytoskeleton changes) 
by synergizing with phosphorylated SLP76 provided by the ligated TCR (Michel and Acuto 
2002).  
   Together, CD28 seems to quantitatively act on the pre-formed TCR-dependent signalling 
block by supplying activated signalling elements (such as AKT, TEK kinases and Vav1) that 
have pleiotropic effects and sustain gene-transcription and TCR-induced activation.  
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2.3.5 Regulators of TCR signalling 
   Tyrosine phosphatases (PTPase) are key regulators of TCR signalling by directly 
antagonizing kinase activity. PTPases have been shown to be important in maintaining T cells 
in resting state (Secrist, Burns et al. 1993) other than being involved in modulation of 
activation threshold and T cell signalling (Mustelin, Rahmouni et al. 2003). In addition to 
CD45, which plays a positive role by antagonizing the kinase Csk (phosphorylates inhibitory 
Y505 of Lck), a number of cytoplasmic PTPase contribute to negatively regulate T cell 
responses at distinct differentiation stages. For instance, SHP1 directly dephosphorylates 
ZAP-70 and Syk kinases, leading to decreased downstream signalling during T cell 
maturation in the thymus, as demonstrated by a general hyper-responsiveness to TCR 
stimulation of both thymocytes and peripheral T cells from SHP1-deficient mice (Brockdorff, 
Williams et al. 1999). Differently, the PTPase PEP, which contains a PEST domain for 
protein degradation, has been shown to specifically dampen responses of effector/memory T 
cell by regulating Lck activity while leaving normal naïve T cell functions (Hasegawa, Martin 
et al. 2004).  
   In addition to PTPase, others signalling molecules such as ADAP (Burbach, Medeiros et al. 
2007), Sprouty (Choi, Cho et al. 2006), Gab2 (Yamasaki, Nishida et al. 2001), Sts-1/2 
(Carpino, Turner et al. 2004) and Cbl (Thien and Langdon 2005) have been shown to 
modulate TCR signalling via processes distinct from direct dephosphorylation. Of interest, in 
mice the regulator Sprouty can exert different effects on TCR signalling depending on the 
differentiation state of the T cell. Indeed, overexpressed Sprouty inhibited TCR signalling and 
decreased IL-2 in Th1 clones, while enhancing TCR signalling and IL-2 production in naïve T 
cells. Sprouty influences both the NFAT and MAPK pathways and may have positive 
functions by sequestrating the inhibitory protein c-Cbl (Choi, Cho et al. 2006). Cbl proteins 
are also critical regulators of T cell development and signalling (Thien and Langdon 2005). 
Since in this thesis I focused on the role of c-Cbl, a member of Cbl family, in regulating the 
functional response of human memory T cells (see RESULT section 6), I will describe this 
protein in more details in a separate section (see following section).  
2.3.5.1 Cbl protein family as negative regulator of TCR signalling 
   The multifunctional adaptor Cbl acts as a negative regulator of TCR signalling mainly by 
catalyzing ubiquitylation and targeting of critical signalling molecules to lysosomal or 
proteosomal degradation (Dikic, Szymkiewicz et al. 2003). In addition, Cbl can modulate 
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activity of signalling proteins and receptors via a yet unknown proteolysis-independent 
mechanism (Naramura, Jang et al. 2002; Dikic, Szymkiewicz et al. 2003; Duan, Reddi et al. 
2004). Intensive research on Cbl proteins originated from the identification of the v-Cbl 
oncogene (Casitas B-lineage lymphoma), which is transduced by the mouse Cas NS-1 
retrovirus and induces pre- and pro-B lymphomas. v-Cbl encodes the amino terminal portion 
(human c-Cbl residues 1-357) of the mammalian c-Cbl protein (Blake, Shapiro et al. 1991), 
which does not possess transforming capacities. In mammalian cells three members of the Cbl 
family have been reported; c-Cbl, Cbl-b and Cbl-3 (Swaminathan and Tsygankov 2006). All 
three homologues share highly conserved regions in their N-terminal halves, which include 
their tyrosine-kinase-binding (TBK) domain, the linker and the RING finger domains. In 
contrast, the C-terminal regions of these family members are less well conserved but they 
have common roles with abilities to interact with a range of SH2- and SH3- domain- 
containing proteins (Swaminathan and Tsygankov 2006). The RING finger domain has a E3 
ubiquitin ligase activity that catalyses ubiquitination, thus targeting critical signalling 
molecules to proteosomal degradation (Fig.9) (Naramura, Jang et al. 2002; Duan, Reddi et al. 
2004). 
 
 
Fig.9 Cbl protein family in mammals.  
All Cbl proteins share a high level of sequence conservation between their TKB, linker (L) and RING finger 
(RF) domains. c-Cbl and Cbl-b have extensive proline-rich regions (black) in their C-terminal halves that 
mediate interactions with numerous SH3-domain-containing proteins. The TKB domain is composed of three 
interacting regions comprising a four-helix bundle (4H), a calcium-binding EF hand and a variant SH2 domain 
that is connected to the RING finger by a short linker domain. The PR domain refers to a PX(P/A)XXR motif 
that binding SH3 domains of regulator of ubiquitin kinase family of proteins. UBA: ubiquitin-associate domain. 
Conserved tyrosine residues are shown in purple. (Thien and Langdon 2005) 
 
 
   Cbl-b is preferentially expressed in peripheral mature T cells while c-Cbl is highly 
expressed in thymocytes (Naramura, Kole et al. 1998). Not surprisingly, c-Cbl was reported 
to play a critical role during T cell development, while Cbl-b was shown to be more important 
in negatively regulating peripheral T cell activation. In contrast, Cbl-3, a shorter homologue 
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of c-Cbl, is enriched in endodermally derived organs, but expressed at very low levels in 
hematopoietic tissues (Fiore, Ollendorff et al. 2001). 
   In Jurkat cells, Cbl-b impairs the recruitment of PI3K to CD28 and indirectly regulates Vav 
activation by inducing ubiquitylation of PI3K activity (Fang, Wang et al. 2001). Cbl-b knock 
out mice show hyperproliferation (Bachmaier, Krawczyk et al. 2000), increased production of 
IL-2 uncoupled from the requirement for CD28 costimulation (Chiang, Kole et al. 2000; 
Krawczyk, Jones et al. 2005) and display auto-immune disorders (Bachmaier, Krawczyk et al. 
2000). In addition, Cbl-b -/- T cells are resistant to induction of anergy (Jeon, Atfield et al. 
2004). 
   In thymocytes, c-Cbl modulates TCR expression, inhibits ZAP-70 activation by an 
unknown mechanism and co-operates with SLP76 to target TCR/CD3ζ to degradation 
(Myers, Sosinowski et al. 2006). Accordingly, c-Cbl KO thymocytes exhibit 
hyperphosphorylation of ZAP-70 and ERK1/2, and TCR signalling uncoupled from CD4 co-
stimulation requirements leading to increased proliferation (Murphy, Schnall et al. 1998) and 
intracellular calcium mobilization (Joazeiro, Wing et al. 1999). Of interest, CD4 peripheral T 
cells from c-Cbl KO mice show a higher functional threshold whereas cells from double Cbl 
KO mice show the phenotype and functions of EM cells (Naramura, Jang et al. 2002). 
However, in these KO mice, Cbl proteins are absent throughout development, therefore their 
role on TCR functions in normally developed T cells remains unclear. Importantly, 
adenovirus-mediated gene expression of dominant negative Cbl (355aa N-terminal residues of 
c-Cbl) in T cells from CAR Tg mice (mice rendered amenable to adenovirus-mediated gene 
expression without the need for T cell proliferation) enhanced cytokine production and 
phosphorylation of key signalling proteins (Vav, Akt, ERK and p38 MAPK) in response to 
CD3 stimulation, thus indicating that inhibition of Cbl function lowers the activation 
threshold of (post-thymic) peripheral T cells (Zha and Gajewski 2007). Finally, 
phosphorylation of Y731, which is unique of c-Cbl, provides a docking site for the SH2 
domains of the p85 regulatory subunit of PI3K, thus enabling c-Cbl to function as a positive 
regulator by recruiting PI3K to the cell membrane (Thien and Langdon 2005) 
 
2.3.6 Role of immunological synapse (IS) in TCR signalling  
   Recognition of pMHC complex by the TCR is strengthened by co-receptors (i.e. CD4 or 
CD8) and co-stimulatory receptor (e.g. CD28) expressed on T cell surface that pair their 
cognate ligands on the APC. The initial TCR-APC adhesion mediated by integrin (e.g. LFA-1 
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/ ligand ICAM-1) and accessory molecule (e.g. CD2 / ligand LFA-3) interactions is followed 
by the formation of a stable but dynamic molecular interface between the two cells which has 
been named the immunological synapse (IS) (also known as supramolecular activation cluster 
– SMAC) (Bromley, Burack et al. 2001). In the central region of the mature IS (named 
cSMAC) are concentrated the TCR, CD4 and CD28 receptors, with associated signalling 
molecules such as Lck or PKCθ. Larger molecules, including LFA-1, CD2 and the 
phosphatase CD45 are excluded from the central region and form a peripheral ring around 
cSMAC known as pSMAC (kinetic segregation model) (Bromley, Burack et al. 2001; Nel 
2002).  
 
Fig.10 The immunological synapse.  
(A) Contact between a T cell (yellow) and an antigen-presenting cell (APC, cyan) (http://www.science.gouv.fr) 
(B) Large-sized tyrosine phosphatases (i.e CD45 – approximately 28-50 nm) are excluded from the cSMAC 
where concentrate small-sized TCR, p-MHC (<15 nm) and co-receptor molecules 
(http://www.rsc.org/ej/SM/2007/b608631d) 
 
 
   The actin cytoskeleton has an important structural role in shaping the IS (Samstag, Eibert et 
al. 2003) and plays active functions in signal transduction, as exemplified by the fact that 
drugs inhibiting actin polymerization interfere with T cell activation (de Mello Coelho, 
Nguyen et al. 2004). Staining experiments with colera toxin B subunit, which binds 
Ganglioside M1, a marker for membrane rafts, clearly demonstrated the presence of lipid raft 
in the IS (Bromley, Burack et al. 2001). Lipid rafts are cholesterol- and glycosphingolipid-
enriched membrane microdomains insoluble in low concentrations of nonionic detergents (i.e. 
Triton X-100) that provide an anchoring site for many key acylated signalling molecules 
(such as Lck, Fyn, LAT…) (Nel 2002). The molecular compartmentalization promoted by 
lipid rafts favors some protein-protein interactions crucial for kinase activity and TCR 
signalling while preventing others, such as the association of CD45 with TCR (Zhang, Trible 
et al. 1998).  
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   TCR activation and early tyrosine phosphorylation precedes IS formation and occurs in 
membrane TCR-microclusters containing activated Lck, ZAP-70 and LAT (Yokosuka, 
Sakata-Sogawa et al. 2005). Subsequent IS formation may contribute not only to the 
stabilization of the signalling complex, but also to the eventual cessation of the signal. The 
precise role of lipid rafts and IS in TCR signalling in naïve, effector and memory T cells are 
not yet known. However, recent evidence suggests that memory cells may have specific 
proteins associated in rafts that may direct differential signalling (Li, Liu et al. 2001). Indeed, 
Li et al. demonstrated that cellular prion protein (PrPc) associates with membrane raft and is 
highly expressed in memory cells following TCR activation (Li, Liu et al. 2001). In addition, 
the increased expression of IS components such as LFA-1 in memory cells, may results in 
formation of stable IS at lower pMHC-TCR affinity. 
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3. Rationale for using Reverse Phase Protein (RPP) arrays 
in this study 
CM and EM T cells represent low frequency cell populations in humans (2.5-13% and 0.8-6% 
of PBMC for CD4 and CD8 memory T cell subsets respectively). Moreover, only limited 
amounts of peripheral blood are available for analysis from each donor (400-450 ml blood or 
100-250x106 PBMC per subject). These limitations represent real technical challenges to the 
study of memory T cell signalling (see PROJECT AIMS) that, therefore, cannot be achieved 
by means of traditional approaches such as western blotting or immunoprecipitation. In the 
last years, new emerging strategies, such as regular/phosphoFACS and protein arrays, have 
been successfully applied for the study of signalling pathways in rare populations of cells 
(Paweletz, Charboneau et al. 2001; Perez and Nolan 2002). Both approaches have unique sets 
of advantages/disadvantages that highlight their complementary nature.  
   PhosphoFACS originated as a refinement of regular flow cytometry applications (cell-
surface marker analysis) and represents an extremely powerful multiparameter method for 
detection of phospho-specific epitopes at single-cell level in heterogeneous cell population 
(Perez and Nolan 2006). However, measuring intracellular antigens by flow cytometry 
requires extensive optimization of both protocols and reagents used (i.e. 
fixation/permeabilization) in order to maintain phospho-epitopes and fluorochrome stability, 
antigen accessibility, cell surface staining and light scatter properties. Moreover, only few 
antibodies work in this format and in many cases phospho-epitope analysis of a particular 
protein are simply not possible because of intracellular localization, low affinity antibodies or 
buried epitopes (Krutzik, Irish et al. 2004). Indeed, upon cell activation and signal 
transduction, phospho-specific epitopes are often buried by protein-protein or protein-
substrate interactions (Schlessinger 2000) and therefore masked after fixation, leading to 
biased results. However, recent experimental evidence suggests that with proper 
fixation/permeabilization reagents, some antigens can be measured efficiently (Krutzik and 
Nolan 2003). Finally, a major limitation in FACS analysis lies in the small signal-to-noise 
ratio when detecting low-abundance signalling proteins, especially generated by the lack of 
signal amplification (Krutzik, Irish et al. 2004).  
   An interesting different approach to study signalling pathways in rare cell populations is 
represented by protein arrays, and in particular the recently described reverse phase protein 
(RPP) arrays (Paweletz, Charboneau et al. 2001). This format (described in details in 
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INTRODUCTION section 4.3.2) allows multiple samples to be analyzed simultaneously on 
the same substrate, greatly increasing throughput and simplifying quantitative comparisons 
between samples. Compared with FACS, RPP arrays use denatured protein/cell lysates and, 
although requiring the handling of homogeneous cell populations, need fewer cells and 
smaller amounts of reagents in parallel experiments. Importantly, most commercially 
available antibodies suitable for western blotting work in this format, provided they are not 
cross-reactive with other proteins (Balboni, Chan et al. 2006). Moreover, signal amplification 
strategies can be applied during array detection and small changes (as little as 20%) in protein 
levels or protein phosphorylation status can be efficiently quantified (See Results) (Chan, 
Ermann et al. 2004).  
   In addition to phosphoFACS and RPP arrays, beads-suspension arrays have been recently 
applied to the multiplex analysis of intracellular signalling pathways (Khan, Mendoza et al. 
2006). However, to date, the limited availability of antibody pairs that function in this format, 
greatly reduces the potential of this approach to well defined applications, such as analysis of 
soluble proteins like cytokines (Szodoray, Alex et al. 2007).  
   Finally, approaches based on mass spectrometry coupled to immunoprecipitation, have 
become powerful tools to identify signalling proteins in a protein complex following 
activation. However, current sensitivity still make this approach unsuitable for the 
characterization of signalling pathways in rare cell populations (Berggard, Linse et al. 2007). 
   Taken together, more meaningful data would result from the combined use of these 
different approaches, but inevitably, at least at the current state of the art, this would result in 
too high costs. Therefore, the choice of the technology platform used in this study was 
dictated by the hypothesis that we wanted to test (study of membrane receptor signalling) and 
the availability of specific reagents and equipment. At the end of 2004 when this project 
started, RPP arrays emerged as the most solid and robust platform for profiling signalling 
protein in rare populations of cells as compared to regular/phosphoFACS and beads-
suspension arrays (Chan, Ermann et al. 2004). To date, RPP arrays still represent the 
methodology that better adapts to our experimental purpose. Indeed, with respect to the other 
approaches, this strategy allows the analysis of a larger panel of signalling proteins, requires 
fewer cells, smaller amount of reagents and has the unique ability to efficiently and reliably 
quantify small changes in protein abundance or phosphorylation state. 
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4. Protein microarray technology 
4.1 History 
   Historically, the roots of protein detecting-microarrays lie in the development of 
immunoassays. As early as 1929, antibodies were used in serology to precipitate antigens for 
subsequent quantification (Heidelberger, M., and F.E. Kendall. 1929. J. Exp. Med. 50:809–
823). Analytical immunoassay technology was greatly advanced with the introduction of the 
radioimmunoassay (RIA) by Yarlow and Berson in 1959 (Yalow and Berson 1959) and the 
enzyme-linked immunosorbant assay (ELISA) by Engvall and Perlman in 1971 (Engvall and 
Perlman 1971). However, the basic concept of microarray technology was initiated only in 
1989 by the ambient analyte model of Ekins and colleagues (Ekins, Chu et al. 1989; Ekins, 
Chu et al. 1990), which states that immunoassay "arrays" (that rely on the immobilization of 
interacting elements on a few square microns) should, in principle, be capable of measuring 
large numbers of different analytes in small samples with a higher sensitivity than 
conventional macroscopic immunoassays. Early biochemical experiments on solid surfaces 
(Fodor, Read et al. 1991; Maskos and Southern 1992) and filter-based assays (Lennon and 
Lehrach 1991), boosted by the completion of the whole-genome sequencing projects, 
culminated with the development of DNA microarrays, the first concrete application of the 
Ekins’s model. Gene expression profiling experiments have generated an unprecedented 
amount of data regarding concomitant genetic events during disease. However, the functional 
consequence of disease is manifested ultimately in the deregulation of protein products and 
protein networks. The realization of this important aspect, coupled with the success of DNA-
based array technologies (platforms and software tools), has finally encouraged the transition 
to protein microarrays (Macbeath and Schreiber, 2000).  
 
 
4.2 Principle and features 
   Protein microarrays consist of protein spots arrayed at high spatial density on a solid 
support (MacBeath 2002; Zhu and Snyder 2003). The spots contain a bait molecule (such as 
antibody, cell or phage lysate, drug, recombinant protein or peptide) that capture 
corresponding binding molecules from a sample (antibody, ligand or serum/cell lysate). 
Readout systems based on fluorescence, chemiluminescence, radioactivity, electrochemistry 
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or label-free methods can be used to detect specific interactions within each microspot. 
Microarray-based assays are crucial to large scale and high throughput biological analysis, as 
they allow true parallelism, miniaturization, multiplexing and automation (Schena, Heller et 
al. 1998). These key features provide a set of performance specifications such as rapidity and 
low cost that can not be obtained with other technologies. Moreover, protein microarrays 
enable profiling of protein levels and their post-translational modifications at a scale that is 
beyond what traditional techniques such as western blot or ELISA can achieve (Balboni, 
Chan et al. 2006).  
   The main current limitation of protein microarrays lies in the limited availability of high 
quality, specific antibodies or suitable protein binding ligands. This necessity has 
strengthened the development of new high-throughput methods for the generation of 
antibodies (Cahill 2001; Zhu and Snyder 2003) and pure functional proteins (Phizicky, 
Bastiaens et al. 2003; Hall, Ptacek et al. 2007). Prior to use on any microarray format, 
antibody specificity and sensitivity must be thoroughly validated (Liotta, Espina et al. 2003). 
A second limitation is the lack of established set of reference standard and reagents for each 
of the various components of protein microarray platforms. Major efforts should be taken in 
this direction since without the establishment of reference standards, it will be difficult to 
interpret results across time and between laboratories and platforms. Currently, several pilot 
studies have been carried out by the International Human Proteome Organization (HUPO: 
http://www.hupo.org) and standards for proteomics are under discussion in different national 
initiatives, such as the German National Genome Research Network (http://www.ngnf.de) and 
the US National Institute of Health Roadmap (‘Standard in Proteomics’- 
http://nihroadmap.nih.gov/buildingblocks/proteomics/).  
 
   Protein microarrays pose a significant set of analytical challenges not faced by gene 
microarrays (Espina, Mehta et al. 2003). The initial challenge is developing a system capable 
of detecting a vast range of analyte concentrations (up to a factor of 1010). The second 
challenge is identifying bait molecules with adequate sensitivity (femtomolar range) and 
specificity for detecting low abundance proteins, since low abundance analyte always exists 
in a complex biological mixture containing a vast excess of contaminating proteins. The third 
challenge concerns the amplification strategy that must be linear and reproducible. Moreover, 
the amplification chemistry must be tolerant to the complexity of the biologic samples that 
can naturally contain molecules, i.e. biotin, peroxidase, etc interfering with the amplification 
process (Hunyady, Krempels et al. 1996). Finally, the last challenge lies in the clinical power 
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of protein microarrays that can only be achieved if the technology is able to handle very small 
amounts of input material. 
 
 
4.3 Array formats and applications 
   Protein arrays have great potential not only in proteomics, but also in many other fields, as 
broad as food industry, commercial diagnosis, quality control and many research disciplines. 
Within this large window of applications, I will focus my discussion on relevant aspect of 
protein arrays in immunology and, in addition, I will mention selected references regarding 
general applications. Particularly, I have organized this chapter into two main sections, 
corresponding to the two current format of protein array: forward and reverse phase (Fig.11). 
 
 
 
Fig.11 Protein array formats.  
(A) Forward phase protein arrays: in this format, a bait molecule (typically an antibody) is directly immobilized 
onto the slide support. The array is subsequently incubated with a test sample containing different analytes and 
the captured molecule detected using label-based method (such as sandwich assay). (B) Reverse phase protein 
arrays: in this format, the whole test sample containing multiple analytes is immobilized onto the slide support. 
The targeted molecules is then detected by incubating the array with specific antibodies.  
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4.3.1 Forward Phase Protein (FPP) arrays 
   In this format a bait molecule, typically an antibody (antibody microarray) or a 
peptide/functional protein (antigen/protein array) is immobilized as individual microspot on 
the substratum. The array is incubated with only one test sample that contains different 
analytes and the captured molecule is subsequently detected using labeled-based or labeled-
free methods (Fig.11A). The use of FPP arrays in immunology has largely been limited to the 
profiling of secreted factors (cytokines, chemokines, growth factors) and autoantibodies. 
4.3.1.1 Antibody arrays 
   In immunology, antibody arrays are traditionally used to quantify serum proteins, such as 
cytokines and chemokines in physiological and pathological conditions, for instance in 
autoimmune disease. Identification and quantification of cytokines contribute to the 
understanding of pathogenesis (e.g. disease classification) (Kader, Tchernev et al. 2005) and 
discovery of new therapeutic targets and novel markers for therapy monitoring. Planar 
antibody arrays were first developed as an extension of the sandwich ELISA platform (Tam, 
Wiese et al. 2002). A capture antibody is spotted on a slide surface, a sample is applied and 
washed, and then a cocktail of labeled detection antibodies is added to bind available epitopes 
on the captured species. Detection is typically achieved with fluorescent- or 
chemioluminescent-based methods giving sensitivity at least equivalent to traditional ELISA 
(Huang, Huang et al. 2001). To further increase sensitivity, multicolor rolling-circle 
amplification (RCA) has emerged as a well-suited detection method. Arrays using RCA 
amplification operate like other multiplex sandwich ELISAs, with the exception than the final 
step involves an oligonucleotide elongation reaction from a circular DNA template. 
Schweitzer et al. first applied this strategy demonstrating simultaneous detection of 75 human 
cytokines with femtomolar sensitivity, 3 log quantitative range and reporting the feasibility of 
time-course analysis of cytokine secretion by mature dendritic cells (DCs) (Schweitzer, 
Roberts et al. 2002). Further optimization of this protocol allowed simultaneous measurement 
of up to 150 cytokines (Shao, Zhou et al. 2003) and analysis of two serum samples on the 
same arrays using two-color RCA detection (Zhou, Bouwman et al. 2004).  
   Besides planar arrays, beads-suspension arrays have been recently developed. In this 
format, optically encoded micron-sized beads serve as surface binder of capture antibodies. 
Since each particle has unique optical properties, multiplexing is possible and beads array 
technologies can easily handle 100 analytes simultaneously. Compared with planar arrays, 
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this approach enables lower cost, higher flexibility and faster analysis of each sample (Nolan 
and Sklar 2002). Clinical applications of this approach include the study of circulating 
cytokines in Sjogren’s syndrome (Szodoray, Alex et al. 2004) and in psoriatic arthritis 
(Szodoray, Alex et al. 2007) versus healthy controls. Both studies revealed the presence of 
disease-state-specific cytokine pattern and suggested biomarkers for diagnosis and disease 
management.  
 
   Other applications of antibody arrays include study of tissue-specific protein expression in 
cancer versus healthy donors (Usui-Aoki, Shimada et al. 2005) and cell-based arrays (Ko, 
Kato et al. 2005).  
   Compared to the existing single analyte ELISA platform all of the above technologies allow 
multiplexing, high-throughput, at least comparable if not higher sensitivity and require 
smaller sample volume. Nevertheless, these technologies are dependent on highly specific, 
high-affinity pairs of binders. Therefore, despite the growing number of successful 
applications, their use is currently limited to specific investigations definable with a relatively 
small set of validated antibodies.  
4.3.1.2 Protein arrays 
   The general concept of protein microarray lies in the immobilization of an antigen or pure 
functional protein/peptide as an individual spot. The array is then probed with a cell/serum 
lysate and the captured molecules are detected. Despite early application to determine 
antibody specificities (Lueking, Horn et al. 1999), protein arrays were first used in 
immunology to characterize the humoral immune response of autoimmune diseases. Indeed, 
autoantibodies are generally directed against evolutionary conserved molecules and have very 
high-affinity and relative high-titer (von Muhlen and Tan 1995).  
Although traditional methods like ELISA, immunoprecipitation and western blot are readily 
available and easy to perform for profiling of a single given autoantigen, they become costly, 
time and labor consuming when analyzing multiple autoantibodies. Moreover, the amount of 
serum needed to test multiple antigens can be limiting, especially in seriously ill or pediatric 
patients. Protein microarrays have the advantage of allowing comprehensive analysis of 
autoantibodies directed against hundreds to thousands of antigens (including proteins, 
peptide, nucleic acids, lipids, ecc) in microliter volume of sera (Robinson, DiGennaro et al. 
2002). Importantly, the amount of serum, time and cost to run the assay remain the same 
regardless of the number of analytes.  
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Joos and colleagues first demonstrated an antigen-microarray based approach to be 
sufficiently sensitive and specific for detecting 18 different serological markers in serum 
samples obtained from human patients with systemic rheumatic diseases (Joos, Schrenk et al. 
2000). In 2002 the first large-scale autoantigen microarray was produced, designed 
specifically for large-scale multiplexed characterization of autoantibody responses. This 
1152-feature connective tissue disease (CTD) array was subsequently tested with either 
monoclonal antibodies or highly characterized serum samples from eight distinct human 
autoimmune diseases (Robinson, DiGennaro et al. 2002). These studies reported sensitivity 4 
to 8 times higher than regular ELISAs over 1000-fold linear range. Using immunoglobulin 
subclass-specific secondary antibodies, these arrays can also be used to characterize 
autoantibody subclasses that may be important in disease pathogenesis. 
   In addition to diagnosis of autoimmune diseases, protein arrays have been used to determine 
IgE reactivity profiles in patients with seasonal allergies (Jahn-Schmid, Harwanegg et al. 
2003), to perform serodiagnosis of infectious disease (Bacarese-Hamilton, Mezzasoma et al. 
2004) and to monitor disease progression and response to therapy (Balboni, Chan et al. 2006). 
Antigen arrays have also been used for the identification of new diagnostic and therapeutic 
targets. Qiu et al. investigated the severe acute respiratory syndrome (SARS) using a protein 
arrayed composed of 13 recombinant proteins of the virus and identified a unique 
immunogenic protein as a promising vaccine candidate (Qiu, Shi et al. 2005). 
 
   Beside the immunological analytical studies reported above, protein arrays have emerged as 
a technology to assess a wide range of functional biochemical activities in many field of 
research (Hall, Ptacek et al. 2007). Indeed, early proof-of-concept studies (MacBeath and 
Schreiber 2000) demonstrated that native proteins immobilized on an array remain 
enzymatically active. Proteome arrays have been used to study protein-protein and protein-
lipid interactions (Zhu, Bilgin et al. 2001), protein-DNA interactions (Hall, Zhu et al. 2004), 
protein-receptor interactions (Jones, Gordus et al. 2006), protein-drug interactions (Huang, 
Zhu et al. 2004).  
 
4.3.2 Reverse Phase Protein (RPP) arrays 
   In contrast to the FPP arrays, which involves immobilizing proteins or antibodies on the 
array surface, the reverse phase approach is based on the immobilization of whole cell lysates 
as distinct microspots (Fig.11B) (Charboneau, Tory et al. 2002). The arrays are then probed 
with highly specific antibodies that recognize a given protein either in a phosphorylation 
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dependent (for detecting activation states) or independent fashion (for measuring protein 
abundance). Bound antibodies are subsequently detected using a secondary antibody directly 
conjugated to a fluorophore (dyes, quantum dots) or enzymes for signal amplification (HRP). 
The preferred amplification strategy for the detection of low abundance signalling protein 
involves HRP-mediated biotin-tyramide deposition, followed by detection by a fluorophore-
conjugated streptavidin (Bobrow, Litt et al. 1992). Since multiple samples (each spot 
represents a different sample) on one array are simultaneously analyzed under the same 
experimental conditions, quantitative comparison between samples is extremely simplified. 
Moreover, only minute amounts of protein extracts are required for the generation of hundred 
of arrays, thus permitting the comprehensive analysis of rare cell types and valuable patient 
samples. In addition, multiple replica and dilution series can be included on the microarray, 
increasing the robustness of protein quantification (Mircean, Shmulevich et al. 2005). 
 
   The concept of RPP arrays was originally described in 2001 by Paweletz et al., in a study 
showing increased phosphorylation of the prosurvival signalling protein Akt and decreased 
phosphorylation of ERK in the transition from normal prostate epithelium to prostate 
intraepithelial neoplasia and invasive prostate cancer (Paweletz, Charboneau et al. 2001). The 
authors could also demonstrate femtomolar sensitivity and a high degree of precision and 
linearity, allowing accurate quantification of signalling proteins.  
The majority of the work accomplished so far using RPP arrays was carry out by Liotta and 
Petricoin’s research groups in the field of oncology. Their studies especially underlined the 
utility of RPP arrays, coupled with laser capture microdissection (LCS) approach, to i) 
discover unexpected signalling defects in tumor specimens relevant for therapy (Petricoin, 
Espina et al. 2007) and ii) identify tumor subtypes based on specific phosphorylation-
signalling signatures (Sheehan, Calvert et al. 2005). For instance, in a recent study, Petricoin 
et al. showed that interlinked components of the Akt/mTOR pathway exhibited increased 
levels of phosphorylation in rhabdomyosarcoma (the most common soft tissue sarcoma in 
children) of patients with short-term survival. The functional significance of this finding was 
verified using CCI-779 inhibitor (mTOR downstream protein inhibitor), that suppressed 
tumor growth in a beige SCID rhabdomyosarcoma xenograft model (Petricoin, Espina et al. 
2007). 
In addition to these studies that use tumor specimens frozen immediately after resection, Chan 
et al. first applied in December 2004 RPP arrays to profile signalling events in stimulated 
living cells (Chan, Ermann et al. 2004). Indeed, they profiled the phosphorylation state of 62 
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signalling components in Jurkat T cells stimulated through TCR/CD3 and CD28 receptors, 
identifying a previously unknown link between TCR/CD3 crosslinking and 
dephosphorylation of Raf-1 protein. Moreover, as a feasibility study, they used RPP array to 
profile the phosphorylation state of 23 signalling proteins in a rare population of T cells. Their 
analysis revealed a differential STAT protein phosphorylation in CD4+CD25+ regulatory T 
cells (Treg) and T cell blasts isolated from naïve mice in response to IL-2 stimulation. 
Importantly, they showed a two-log linear range and a detection limit of one protein in 105 to 
106 lysate protein. 
   In this thesis work this strategy has been applied for the first time to perform an analysis of 
signalling pathways in rare human cell populations isolated ex-vivo, allowing us to accurately 
quantify signalling proteins from as little as 20 cell-equivalents per spot. We profiled 16 
signalling parameters in human memory CD4 and CD8 T cell subsets. Among the differences 
identified, we demonstrated that decreased content of the negative regulator c-Cbl in effector 
versus central memory CD4 T cell subsets is responsible for their different functional 
responsiveness (see RESULTS). 
 
   The main limit of RPP arrays lies in its dependency on commercially-available highly-
specific antibodies. Nevertheless, compared with other technologies (i.e. FPP arrays and 
phosphoFACS), RPP arrays is the approach that suffers the least from this drawback. Indeed, 
RPP arrays do not require chemical modification of the antibodies and, in addition, their 
validation can be carried out by regular western blotting immunodetection. Moreover, most of 
the commercially available antibodies suitable for western blotting work in this format, 
provided that they have no cross-reactivity with other proteins in the sample analysed. 
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   Two subsets of human memory T cells (central and effector memory) have been described 
based on the surface expression of the phosphatase CD45 and the chemokine receptor CCR7 
(see INTRODUCTION section 1.2.2). These subsets display a high functional heterogeneity 
and have critical and distinct roles in the control of protective immunity. However, the 
biochemical mechanisms controlling the functional properties of memory T cell subsets are 
still unknown and remain poorly investigated. Their clarification is crucial for a rational 
design of effective T-cell vaccines and for the identification of new molecular targets for drug 
development. Major limitations to these studies lie in the technical challenges imposed by the 
low frequency of memory T cell subsets and the limited amount of human specimens 
available for analysis that make traditional protein profiling approaches inadequate.  
 
   The aim of this is the identification of the mechanisms responsible for the functional 
heterogeneity that characterizes human central and effector memory T cell subsets. In 
particular, we hypothesized that this heterogeneity derives from a different 
composition/regulation of the signalling machinery and/or a differential assembly/recruitment 
of the TCR signalling complex components in these cells. 
 
   Our first hypothesis has been successfully investigated in this thesis thanks to the 
implementation of reverse phase protein arrays, which represent a highly sensitive and 
quantitative protein profiling approach for the study of rare cell populations. Critical 
differences in the global composition of the signalling machinery of memory T cell subsets 
were identified and correlated with the functional properties of these cells. 
   Our second hypothesis remains currently under investigation. However, a technical 
approach has been developed and validated to achieve this aim.  
 
   The results obtained from the sets of experiments presented in this thesis are part of the 
following manuscripts: 
1) Brembilla NC, Weber J, Rimoldi D, Pradervand S, Schutz F, Pantaleo G, Ruegg C, 
Quadroni M, Harshman K, Doucey MA. c-Cbl expression regulates the functional response of 
human central versus effector memory CD4 T cells. Blood. 2008 Aug 1;112(3):652-60.  
2) Brembilla NC, Cohen-Salmon I, Weber J, Rüegg C, Quadroni M, Harshman K and Doucey 
MA. Profiling of T cell receptor signaling complex assembly in human CD4 T lymphocytes 
using reverse phase protein arrays.  Proteomics. (in press) 
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5. Implementation of RPP arrays to profile signalling 
proteins in human memory T cell subsets 
   The first objective of this thesis lies in the comprehensive analysis of the composition of the 
signalling machinery of human central and effector memory T cells isolated ex-vivo. 
However, the low frequency of memory T cell subsets and the limited amount of human 
specimen available for analysis make traditional protein profiling approaches inadequate. To 
address these issues, we established and implemented a technological platform able to 
accurately quantify signalling proteins and their modifications in minute amount of cells.  
The technology we selected and implemented was Reverse Phase Protein (RPP) arrays. The 
rationale for using this approach is discussed in details in INTRODUCTION section 3. 
   RPP arrays were initially applied in 2001 by Paweletz et al. for the characterization of 
signalling defects in prostate cancer biopsies (Paweletz, Charboneau et al. 2001). 
Subsequently, at the end of 2004 and concomitantly with the beginning of this thesis project, 
Chan et al. adapted this technology to monitor signalling events in living cells (Chan, Ermann 
et al. 2004).  
   In this chapter, I report the implementation of RPP arrays for the profiling of signalling 
proteins in highly purified subsets of human memory T cells isolated ex-vivo. This work was 
conducted in collaboration with the DNA Array Facility (DAF, CIG, Lausanne) of the 
University of Lausanne and led to the set-up of RPP array technology for the first time in 
Lausanne (http://www.unil.ch/dafl/page44650_en.html).  
The results described in this section are also part of a manuscript accepted for publication in 
PROTEOMICS journal (www.proteomics-journal.com) on August 2008 (see PROJECT 
AIMS). 
 
 
5.1 Design and fabrication of RPP arrays 
   To fabricate our RPP arrays we used the contact-printing robotic microarrayer Omnigrid 
300 fitted with SMP3 solid pins that deliver approximately 0,7 nl of whole cell lysate per 
spot onto a slide containing 16 distinct 3D-nitrocellulose pads. One pad accommodates 21 
different samples printed in triplicate. A 21 pad-specific series of samples is then replicated 
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along the 16 pads of a slide. Each pad can be treated independently by using a 16 well leak-
proof incubation chamber, thus allowing 16 simultaneous detections on 21 different samples 
(Fig.12A) on the same slide. 
   After blocking, pads were probed with specific primary antibodies, followed by HRP-
secondary antibody incubation. To ensure detection of low-abundance signalling molecules, a 
Catalyzed Reporter Deposition (CARD) Amplification step was introduced (Bobrow, Litt et 
al. 1992). Briefly, HRP catalyzes the formation of reactive biotin-tyramide intermediates that 
covalently attach to tyrosine residues of surrounding proteins. The half life of the 
intermediates is so short that deposition occurs only close to the HRP. Bound biotin was 
detected with streptavidin-Cy3 and signal intensities measured using a microarray scanner 
(Fig.12B). Gain in signal intensity after the amplification step was in the range of 8 to 30 fold 
(Fig.12C). 
 
 
Fig.12 RPP arrays: equipment and detection strategy.  
(A) Contact-printing robotic microarrayer OMNIGRID 300 (left panel). Representation of a 16-pad nitrocellulose-
coated glass slide. Each pad contains 21 different samples printed in triplicate and can be treated independently 
by means of a leak-proof chamber (right panel). (B) RPP arrays detection strategy: 1. primary Ab (red), 2. HRP-
linked secondary Ab (blue), 3. CARD amplification step (black), 4. Streptavidin-Cy3 (green). (C) gain in signal 
intensity after CARD amplification. 
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5.2 Octylglucoside-containing lysis buffer allows optimal protein 
retention on 3D nitrocellulose-coated slide  
   Cell lysate quality is of critical importance to the reliability and outcome of RPP arrays 
(Winters, Dabir et al. 2007). Indeed, different detergent-containing lysis buffers have unique 
solubilization properties and behavior with respect to protein solubilization and retention on 
3D nitrocellulose. Protein extraction buffers for RPP arrays usually contain SDS as detergent 
and have been mainly applied to the solubilization of tissue (Sheehan, Calvert et al. 2005) or 
cell lines (Nishizuka, Charboneau et al. 2003; Chan, Ermann et al. 2004). However, the 
impact of the detergent on lysate retention on 3D nitrocellulose remains still unknown. This 
thesis is the first study that investigates signalling proteins in ex-vivo isolated human T cells 
using RPP arrays, and therefore no established and validated lysis conditions for these cells 
were available. 
   An optimal extraction buffer has to meet the three following criteria: i) it contributes to 
protein denaturation, ii) it allows efficient protein solubilization including proteins associated 
to lipid rafts (often the case for signalling protein) and iii) it shows minimal interference with 
protein retention on the RPP array surface (i.e 3D nitrocellulose).  
   To allow a direct comparison of the detergent effects, ex vivo isolated human CD4 T cells 
from the same subject were lyzed using Triton X-100 (TX), Triton X-100/SDS (TX/SDS) and 
octylglucoside (OG)-containing buffers. Importantly, lipid rafts are resistant to TX 
solubilization while efficiently solubilized by OG or SDS-containing buffers (Doucey, Legler 
et al. 2001). CD4 T cell lysates obtained with the three different buffers were serially diluted 
and each condition arrayed as triplicate spots on the same pad, which was subsequently 
detected with antibodies specific for the T cell adaptor protein c-Cbl. The impact of the 
different detergents on protein retention on 3D nitrocellulose was evaluated based on signal 
intensity, sensitivity, dynamic range and reproducibility. The buffer containing TX, a 
detergent unable to solubilize lipid raft, displayed a marked loss in signal intensity and 
dynamic range compared to TX/SDS- or OG-containing buffers which, in contrast, produced 
strong and comparable signal intensities. However, while TX/SDS-based buffer repeatedly 
resulted in a loss of dynamic range at higher lysate concentration, OG-based buffer produced 
a reproducible linear regression between signal intensity and lysate concentration covering 
two orders of magnitude (Fig.13A).  
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Fig.13 Octylglucoside containing CD4 T cell lysates are optimally retained on 3D nitrocellulose.  
(A) T cells were lysed in TX-100, TX-100/SDS mixture or octylglucoside (OG) containing buffers. Increasing 
dilutions of protein cell lysates were printed on 3D nitrocellulose slide. Shown is the mean fluorescence intensity 
(MFI) of c-Cbl detected in triplicate spots with specific antibodies. (B) Solubilization efficiency of the different 
detergent-containing buffers as measured by total protein content of soluble (S) or insoluble (INS) fractions. 
Following fractionation of the lysates by SDS-PAGE, total proteins from the gel were stained with Coomassie 
Blue and quantified with Image J software. (C) Protein retention efficiency on 3D nitrocellulose-coated slide is 
not affected by protein to OG ratio. T cell proteins were labelled with the fluorescent cell tracker DDAO, lyzed, 
mixed with unlabelled T cell lysate at a 3/97 ratio and serially diluted in lysis buffer (left panel, increasing 
DDAO /detergent ratio). Conversely, increasing amounts of unlabelled lysate were added to a constant amount 
(1.5% of total proteins) of DDAO-labelled T cell lysate (right panel, DDAO/detergent ratio constant). Actin and 
DDAO signals were detected in triplicate spots. One representative experiment out of three is shown. 
 
 
   The efficiency of protein solubilization produced by these buffers was assessed by SDS-
PAGE using samples obtained under the same experimental conditions. Surprisingly, signal 
intensities obtained after RPP arrays did not directly reflected the efficiency of protein 
solubilization as assessed by SDS-PAGE. Indeed, while TX-SDS and OG signal intensities 
obtained by RPP arrays were comparable and higher than the one obtained with TX 
(Fig.13A), protein solubilization achieved with TX-SDS was only slightly higher (+15-20%) 
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as compared with the other buffers (Fig.13B). Thus, linear and robust spot signal intensities 
from crude T cell lysate results from a complex process involving the efficiency of protein 
solubilization and the interference of the detergent on protein retention on 3D nitrocellulose. 
For further experiments, OG- was preferred to TX/SDS-containing buffers due to its lager 
dynamic range and better linearity (Fig.13A). 
   We next examined whether the protein content of the lysate affected the efficiency of 
protein retention on 3D-nitrocellulose when printing is performed at constant OG 
concentration (thus changing protein/detergent ratio). T cells were treated with DDAO-ester 
to fluorescently label membrane and cytosolic proteins, lyzed, mixed with unlabelled T cell 
lysate and serially diluted in lysis buffer. As expected, in this condition where DDAO and 
total protein/detergent ratio were increased, both actin and DDAO signals increased in a linear 
and parallel fashion (Fig.13C, left panel). In contrast, when a constant amount of DDAO 
lysate was supplemented with increasing amount of unlabelled lysates (thus increasing 
protein/detergent ratio but keeping constant DDAO/detergent ratio), DDAO signals remained 
unchanged while actin signal linearly increased (Fig.13C, right panel). Similar results were 
obtained when cytosolic (Syk) or membrane-associated proteins (Lck, FcRγ) were detected 
(data not shown), thus confirming no significant impact of OG on protein retention over the 
range of lysate dilutions examined. Together, OG-containing lysis buffer displays comparable 
solubilization efficiency with respect to TX and TX-SDS based buffers while allowing better 
protein retention on 3D nitrocellulose and larger dynamic range.  
 
 
5.3 RPP arrays display excellent performance characteristics 
   In order to enable statistical analysis and to increase the robustness of the data, each sample 
used in this thesis project was printed as triplicate spots. A single spot contained 2 to 5 ng of 
proteins from total T cell lysate, which correspond to the protein equivalent of roughly 20 to 
50 T cells.  
   Qualitative analysis of the spots revealed an average diameter of 209±15 µm per spot and a 
circularity of 93,5 % (circular shape=100 %). Coefficient of variation (CV) intra-triplicate and 
inter-sample were respectively 2,9% and 6,9% for diameter and 2,2% and 1,9% for circularity, 
revealing that diameter, but not circularity, was slightly sample-dependent. Good signal 
reproducibility was achieved, with CV within triplicate spots from 200 samples less than 
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5.6%. Similarly, inter-pad variability of replicated samples (re-print of 21 samples on 16 pads 
of the same slide) was ranging from 3 to 6% in low to high protein lysate concentrations, 
respectively (Table 1). 
 
 
 
 
 
 
 
Table 1. Qualitative analysis of the spots.  
Geometry and intensity of the spots were evaluated by calculating the Coefficient of Variation (CV) intra-
triplicate or inter-samples. * refers to inter-pad variability (right panel). Representative spots are shown (left 
panel). 
 
 
   Specificity of the signal was assessed by measuring SLP-76 expression in peripheral blood 
mononuclear cells (PBMC) and colon carcinoma Caco-2 cells, where it is expressed and not 
expressed, respectively. Signal specificity was further demonstrated by detecting RNase-2 in 
PBMC lysates supplemented or not with exogenous RNase-2 (Fig.14A).  
    Since each antibody is unique in its binding affinity for its cognate antigen, we determined 
its specific dynamic range by including a lysate serial dilution in the same pad containing the 
samples to analyze. For most of the antibodies used, signal linearity was demonstrated in 
spots containing 5 to 200 cell equivalent (Fig.14B and data not shown). An antibody was 
used for RPP arrays only if it detected by immunoblotting a single band of the expected 
molecular weight in a biological sample similar to that analyzed on the arrays (Fig.14C). 
   Together, these data show that RPP array approach possess performance characteristics that 
are largely beyond what traditional technologies can achieve and therefore can be suitable for 
the profiling of protein levels in minute amount of cells. Of note, the amount of cells required 
for the quantification of a single signalling protein by immunodetection of Western Blot (e.g. 
c-Cbl ~300000 cells) is sufficient to print more than 4000 spots on RPP arrays. 
 
 
circularity=93.5% 
diameter=209µm 
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Fig.14 Performance characteristics of RPP arrays.  
(A) Mean Fluorescence Intensity (MFI) of SLP-76 specific signals detected in spots containing equal protein 
amount of PBMC or intestinal Caco-2 cell lysates (left panel). Alternatively, exogenous RNase-2 was added to 
PBMC lysate and specific RNase-2 signals were normalized to β-actin content (right panel). (B) Quantitative 
analysis of Lck detection in serially diluted PBMC lysates using specific antibodies. Corresponding spots printed 
in triplicate are shown. (C) Immunodetection of Western Blots with specific antibodies for SLP-76 and RNAse-
2 in the lysates as shown in A.  
 
 
5.4 Analysis of T cell populations using RPP arrays   
   The RPP array technology described above has been validated and used in this thesis to 
profile the abundance of 15 relevant signalling proteins in ex vivo isolated human CD4 and 
CD8 memory T cell subsets in 8 to 13 healthy subjects (see RESULTS section 6.1). As 
described in details in RESULTS section 6.1, highly purified CD8 and CD4 T cell subsets 
(naïve -N-, central memory -CM-, effector memory -EM- and effector -E- cells) were isolated 
by cytofluorimetry, lyzed and arrayed as triplicate spots on a nitrocellulose-coated slide that 
was subsequently detected with antibodies against the targeted signalling proteins. Since ex-
vivo isolated T cell populations do not display the homogeneity of T cell lines or clones, 
combined analysis of distinct subjects was needed to reach statistical robustness. Thus, in this 
study three sources of variability can be identified: variability in the amounts of total protein 
printed per spot, inter-subject variability, and experimental variation (i.e. technical error). It is 
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crucial to take these variabilities into account when comparing the relative abundance of a 
signalling protein among the different T cell subsets. 
 
   Variation in spotting and sample preparation were adjusted by normalizing the mean signal 
intensity of each triplicate spot (one sample) to the corresponding mean intensity of β-actin 
signal, which serves as an internal marker for total protein deposition. Indeed, we show that 
the amount of actin per mg of protein lysate was constant in the different T cell subsets, while 
β2-microglobulin (Fig.15) or tubulin levels (data not shown) varied considerably. Signalling 
protein/actin ratios were calculated by probing identical pads on the same slide with actin-
specific antibodies. Since normalization is introduced, accurate quantification of protein 
abundance was possible only when signalling protein and actin signals were included in their 
dynamic range. The dynamic range, defined as the linear range of detection of a specific 
protein, was determined by detecting a serial dilution of a CD4 T cell lysate in the same pad 
of the samples analyzed.  
 
 
 
 
   The relative error in signal intensity ratio (signalling protein/actin) represents an estimation 
of the technical error in the quantification of the signalling components. It was assessed by 
analyzing the CV within triplicate spots of the parameters under study (n=15) in 200 distinct 
cell extracts from 10 distinct subjects and ranged from 10.3 to 11.4% in the different T cell 
subsets (table 2). Based on the technical error (~11%), changes higher than 20% in the 
quantification of signalling protein were considered as potentially significant. 
 
 
Fig.15 β-actin as protein for normalization.  
β-actin and β2-microglobulin contents were measured 
in lysates of sorted N, CM, EM and E cells following 
SDS-PAGE and immunoblotting with specific 
antibodies. Shown are representative immunodetection 
and quantitative measurements of β-actin signals from 
WB in three cumulated subjects 
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   To avoid biases generated by the inter-subject variability, each subject was considered as 
independent from the others when cumulated analyses were performed. Significant changes in 
the expression levels of signalling protein between two subsets were calculated within each 
subject using paired t-test (see RESULTS section 6.1, Fig.18 – individual graphs). Changes 
were considered as significant when higher than 20% and calculated p-value of two-tailed 
paired t-test was less than 0.05.  
   Alternatively, in order to represent only the differences identified among the different T cell 
subsets (having no interference of the inter-subject variability) the data were plotted using a 
heat-map (see RESULTS section 6.1, Fig.18 – heat-maps). Relative fold increase in signalling 
protein for each subject was calculated by internally normalizing the measurements obtained 
in the different T cell subsets to a cell subset used as “normalization subset”. In this study, we 
selected a priori as subset for normalization N cells because they have never encounter their 
cognate antigen and can be considered as precursor of the other cell subsets. Consistently, 
analysis of our data revealed that N cells displayed the highest inter-subject homogeneity for 
the majority of signalling component analyzed (see RESULTS section 6.2). Data were 
subsequently logged in base 2, in order to compensate for the asymmetry introduced by the 
ratio used in the normalization to N cells (e.g quantification CM / quantification N). log2 
ratios derived from the analysis of different subjects were finally combined by calculating the 
mean log2 ratio for each signalling protein and displayed in continuous colour scale on a heat-
map (see RESULTS section 6.1, Fig.18 – heat-maps). 
 
 
 
 
 
Table 2. Evaluation of the coefficient of variation in 
the spot intensity in the different T cell subsets.  
A total of 200 triplicate spots and 15 different 
signalling components were examined for each T cell 
subset. The means of the coefficient of variation in 
signal to β-actin ratio (CV~CVprotein+CVβ-actin) within 
triplicate spots were calculated from 10 subjects. 
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5.5 RPP arrays as a tool to profile TCR signalling complex assembly  
   The functional heterogeneity of memory T cell subsets may result from a different 
composition of their signalling machinery as well as from a different organization of their 
TCR signalling complex. Indeed, signalling complexes are highly dynamic cluster of 
interacting proteins essential for efficient signal propagation from the cell membrane to the 
nucleus. While the profiling of signalling components in memory T cell subsets can be 
assessed using RPP arrays as demonstrated in RESULTS section 6.1, the analysis of TCR 
complex assembly in this cells remains an issue. To date, the most widely used experimental 
methods to study protein interactions are two hybrid screens (2HS) and mass spectrometry 
(MS)-based approaches combined to affinity capture. However, MS-based approaches require 
relatively large amounts of cells (108 to 109) due to the low abundance and high breakdown of 
molecular complexes during isolation and purification procedures (Yang, Steen et al. 2008). 
Since such amounts of cells are impossible to obtain working with ex-vivo isolated human 
memory T cell subsets (e.g. highly purified CM CD8 cells <6 x106 cells per donor; EM CD4 
cells <1,4 x107 cells per donor), we developed an alternative strategy based on RPP arrays to 
overcome this limitation. By combining small-scale affinity capture of TCR and RPP arrays 
we reported specific recruitment of signalling proteins to the TCR complex upon T cell 
activation in as few as 0.5 x106 cells. Since this technology has not been used in this thesis 
project to compare TCR signalling complex assembly in CM and EM cells (see 
DISCUSSION and PERPECTIVES), I will report in this section only a brief description of 
the strategy and the main results obtained. 
 
   The strategy developed in the laboratory consists of a two-steps procedure. TCR complexes 
are first captured from a non-denaturing T cell lysate by TCR/CD3ε antibodies covalently 
immobilized at the bottom of micro-wells (2 mm in diameter) built at the surface of an 
aldehyde-derivatized glass slides. Following washing out of the contaminants, isolated 
complexes are then eluted under denaturing condition and arrayed on nitrocellulose-coated 
slide to allow efficient profiling of their components by RPP arrays (Fig.16) 
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Fig.16 Analysis of TCR-signalling complex assembly.  
Silicone rubber manifold was used to generate chambers of 2 millimeters in diameter at the surface of an 
aldehyde glass slide. Anti-TCR/CD3ε antibodies were covalently linked to the glass surface to capture 
TCR/CD3 signalling complexes from human CD4 T cell lysates. Immuno-captured TCR complexes were 
washed free of contaminants, recovered under denaturing conditions and their composition analyzed by RPP 
arrays. 
 
 
   This approach was validated by profiling the changes in TCR signalling complex 
composition upon activation in CD4 T cells. To this end, 0.5x106 ex vivo isolated CD4 cells 
from human peripheral blood were subjected to polyclonal stimulation using anti-CD3 
antibodies over a period of 20 min. TCR complexes were immuno-isolated and their content 
in CD3ζ, Src kinases Lck and Fyn, and ZAP-70 kinase was determined by RPP arrays. CD3ε 
and Hsp-90 were used for normalization and as negative control, respectively. The 
recruitment of signalling molecules to the TCR complex was measured as the percentage of 
increase relative to the resting state (time zero, Fig.17A). In agreement with the T cell 
signalling pathway (see INTRODUCTION section 2.3.3), we observed a specific and strong 
recruitment to TCR/CD3ε of Src (Lck and Fyn) and ZAP-70 kinases. Notably, Hsp-90 spot 
intensities remained close to background level. Finally, CD3ζ dissociation from CD3ε 
subsequent to ZAP-70 and Src kinase recruitment (Fig.17A) was consistent with the reported 
ubiquitylation-mediated degradation of TCR/CD3ζ induced by Lck and ZAP-70 activation 
(Call and Wucherpfennig 2005). Importantly, the whole kinetic analysis required only 2 
millions of CD4 T cells. Cumulated data from three distinct subjects showed homogenous 
results, confirming the reliability of this approach (Fig.17B)  
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Fig17. Kinetic of TCR-signalling complex assembly upon T cell activation.  
(A) Following activation with anti-TCR/CD3ε and -CD28 antibodies over 20 min, CD4 T cells were lysed and 
their TCR/CD3 complexes captured and analyzed as described in Fig.16. The recruitment of TCR/CD3ζ, Lck, 
Fyn, ZAP-70 and Hsp-90 to TCR/CD3ε at different time post activation was measured by RPP arrays. Shown is 
the percentage of increase in intensities normalized to TCR/CD3ε and relative to unstimulated cells (time zero). 
One representative kinetic out of three is presented. (B) Recruitment of signalling molecules to TCR/CD3ε 
following 5 min of activation as shown in A). Shown are data obtained from three distinct subjects 
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6. c-Cbl expression regulates the functional response of 
human central versus effector memory CD4 T cells 
   The aim of this thesis is to identify the signalling patterns that define the functional 
heterogeneity of ex-vivo isolated human central and effector memory T cells. This functional 
heterogeneity may derive from a differential regulation of the signalling pathways 
downstream of the TCR. In order to assess this hypothesis, we first profiled by RPP arrays the 
expression levels of the main signalling components in these cells. Understanding the 
mechanisms at the basis of this functional heterogeneity is critically important to better 
characterize protective immunity and to design efficient vaccine strategies. 
   At present, few and contrasting studies (mainly done in mouse) have investigated the 
expression of signalling proteins (Farber, Acuto et al. 1997; Bachmann, Gallimore et al. 1999; 
Hall, Heffernan et al. 1999; Hussain, Anderson et al. 2002; Krishnan, Warke et al. 2003) and 
gene transcription (Chtanova, Newton et al. 2005; Willinger, Freeman et al. 2005; Riou, 
Yassine-Diab et al. 2007) in memory T cell. In humans at the beginning of 2007, lower 
transcription of proapoptotic FOXO3a target genes have been correlated with enhanced 
survival of central versus effector memory T cells (Riou, Yassine-Diab et al. 2007). However, 
no study has yet investigated the expression of signalling proteins in these subsets, mainly 
due to the limited amount of cells available in human specimens.  
   Thanks to the implementation of the RPP array technology described in detail in RESULTS 
section 5, we performed analysis of 15 main signalling components in ex-vivo isolated human 
CD8 and CD4 memory T cell subsets. In contrast to CD8 cells, we showed that the 
composition of signalling machinery among the CD4 cell subsets differed remarkably. 
Moreover, we identified for the first time that the functional response of CD4 memory T cell 
subsets depends on specific variations of critical proteins downstream of the TCR. Indeed, we 
demonstrated that the adaptor/regulator protein c-Cbl plays a crucial role in modulating the 
functional responses of effector memory cells through a mechanism mainly dependent on its 
E3 ubiquitin ligase activity.  
   The results described in this section are part of a manuscript that has been accepted for 
publication in BLOOD, Journal of the American Society of Hematology 
(http://bloodjournal.hematologylibrary.org) on April 2008 (see PROJECT AIMS). 
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6.1 Expression of signalling components in human CD8 and CD4 T 
cell subsets  
   To understand how TCR triggering directs different functional outcomes in memory T cell 
subsets, we first profiled 15 signalling components using RPP arrays. Highly purified (purity 
>98%) CD8 and CD4 T cell subsets were isolated by cytofluorimetry based on their surface 
expression of the phosphatase CD45RA and the CC chemokine receptor CCR7, molecules 
which define their distinct functional and homing capacities (Sallusto, Lenig et al. 1999): 
naïve (N; CD45RA+, CCR7+) central memory (CM; CD45RA-, CCR7+), effector memory 
(EM; CD45RA-, CCR7-) and terminally differentiated cells (E; CD45RA+, CCR7-). Cells 
were lyzed and arrayed as triplicate spots on a slide pad containing a serial dilution of CD4 T 
cell lysate used to determine the amplitude of the linear range. The number of E CD4 T cells 
in peripheral blood of healthy donor is extremely limited (0.5 to 1% of CD4 T cells) and thus 
this population was not investigated. Data processing and statistical analysis of the slide was 
performed as described in RESULTS section 5.4. Changes in the expression of a signalling 
component between two cell subsets were considered as significant when higher than 20% 
and calculated p-value of two-tailed paired t-test was less than 0.05. As a control of efficient 
protein denaturation, we used antibodies recognizing N- and C- terminal end of the Src kinase 
Lck. Comparable results were obtained in both cases, thus indicating fully denaturing 
conditions. 
 
   The examination of different CD8 T cell subsets in 8 to 13 healthy subjects revealed a 
comparable and homogenous composition of the signalling machinery with EM and E cells, 
relatively to CM cells, expressing significantly increased amounts of p38MAP (p<0.05) but 
not of the functionally related ERK1/2 (p>0.05, Fig.18A). Although PLCγ and Fyn 
expression increased consistently from CM to EM cell subsets (p<0.05), the amplitudes of 
these increases were close to 20% (19.5 to 20.1%) and therefore, based on our criteria, not 
further investigated (Fig.18A, left panel and data not shown). Taken together, our data 
showed that CM cells were significantly more closely related to N cells than EM or E cells 
(Fig.18A), in agreement with their gene expression and cytokine signalling profiles 
(Willinger, Freeman et al. 2005).  
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   In contrast, CD4 memory T cell subsets showed more profound changes in the expression 
levels of specific signalling components. Indeed EM cells expressed significantly increased 
amount of SLP-76 (p<0.05) and reduced levels of c-Cbl (p<0.001), Syk (p<0.001), Fyn 
(p<0.01) and LAT (p<0.05) as compared to CM cells (Fig.18B). Importantly, three out of the 
five proteins showing significant changes in their expression levels are adaptor molecules: c-
Cbl, SLP-76 and LAT. The largest differences were observed for Syk (-46%) and these 
adaptor molecules (-33 to -35%, Fig.18B). Finally, the changes in the expression of Lck and 
PI3K were lower than 20% and not significant, respectively. 
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Fig.18 Analysis of the signalling components in CD8 (A) and CD4 (B) T cell subsets. 
 Signalling components were quantified by RPP arrays and normalized to β-actin in the different T cell subsets. 
The colours indicate the mean log2 ratios of signalling components relative to N cells from 8 to 13 subjects. 
Signalling components showing significant differences (two-tailed paired t-test p<0.05, shown in red) between 
CM and EM cells are represented as row ratios on individual graphs. CM and EM compartments are shown in 
black. Each set of linked dots correspond to a distinct subject and n indicates the total number of subjects 
examined. Lck was detected using specific antibodies recognizing epitopes located at the N- and C-terminal ends 
of the protein (Lck N and Lck C, respectively) to ensure fully denaturing conditions. 
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6.2 Heterogeneity in the expression of the signalling components 
among subjects in CD4 and CD8 T cell subsets  
   We observed that the variations in the expression of signalling components among the 
subjects were higher than the technical error (Figure 3, median 21.5-28.5% > technical error 
11%) and are thus likely to represent inter-subject heterogeneity. Furthermore, a limited 
number of signalling components showed drastically high inter-subjects heterogeneity (up to 
63%): LAT, Syk and CD3ζ  in memory CD4 T cells (Fig.19A); ZAP-70, SLP-76 and PLCγI 
in memory CD8 T cells (Fig.19B). These variations were independent of the signalling 
parameter examined and moreover restricted to specific T cell subsets such as observed for 
CD3ζ and Syk in EM, but not CM CD4 T cells (Fig.19A). In memory CD4 cells, subject 
heterogeneity increased from CM to EM cells along CD3ζ/Syk/LAT pathway (Fig.19A). In 
CD8 T cells, overall subject heterogeneity increased with cell differentiation with signalling 
components being significantly (p<0.05) more homogenous in N than in memory and effector 
cells (see median lines in Fig.19B). The expression of SLP-76 and PLCγ among the subjects 
was highly heterogenous in both memory CD8 T cell subsets while heterogeneity in ZAP-70 
expression increased from CM to EM cells (Fig.19B). Finally, Lck was the most 
homogeneously expressed protein among subjects in all CD4 and CD8 T cell subsets (data 
not shown). 
 
 
 
Fig.19. Subject heterogeneity in the expression of signalling components in CD4 and CD8 T cell 
subsets. Subject heterogeneity as expressed by CV of the 15 signalling components (n=15) under 
study in 8-13 cumulated subjects in CD4 (A) and CD8 (B) T cell subsets. Box plots were 
automatically generated using GraphPad, the box represents values between 25th and 75th percentile 
with a line at the median (50th percentile). The whiskers extend above and below the box to show the 
highest and the lowest values. Shown are signalling components with highest subject heterogeneity in 
CM or EM cells. 
 -62- 
6.3 In CD4 EM T cells, reduced expression of c-Cbl correlates with 
LAT, SLP-76 and PI3K content 
  Examination of c-Cbl expression levels in 10 subjects by RPP arrays revealed a 34% 
reduction in EM as compared to CM CD4 T cells (p<0.001, Fig.18B, 20A). c-Cbl 
immunoblots of T cell lysates from four different subjects confirmed the result obtained by 
RPP arrays (Fig.20A and C). Importantly, in contrast to c-Cbl, CM and EM cells showed 
similar levels of Cbl-b expression (homologue of c-Cbl) (Fig.20D). Cbl proteins are 
multifunctional adaptor proteins acting as key negative regulators of T cell signalling mainly 
through an ubiquitin-dependent mechanism (see INTRODUCTION section 2.3.5.1).  
 
 
Fig.20 c-Cbl, but not Cbl-b expression is reduced in EM CD4 T cells.  
(A) Quantification of c-Cbl expression levels in CM and EM cells by RPP arrays and immunodetection of 
Western Blots with antibodies specific for c-Cbl and actin. Shown are c-Cbl to actin ratios in 10 (RPP arrays (), 
30 cells equivalent/spot) or 4 (WB (O), 300 000 cells equivalent/lane) distinct subjects. Examples of detected 
spots (B) and quantified immunodetections (C) are shown. (D) Quantification of Cbl-b by RPP arrays in nine 
subjects as described in A. 
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   To understand how c-Cbl impacts memory T cell signalling, we compared its expression to 
the other signalling proteins. We observed a linear correlation of the expression of c-Cbl with 
the adaptors SLP-76 and LAT (Pearson r=0.78, p=0.022 and r=0.92, p=0.0001 respectively) 
and PI3K (r=0.84, p=0.0084), suggesting that these proteins might be co-regulated (Fig.21A). 
Interestingly, these correlations were specific to EM cells and restricted to c-Cbl and SLP-76 
in CM cells (r=0.89, p=0.0028, Fig.21A, first panel). Among the signalling parameters 
examined, only one additional significant correlation was observed between CD3ε and ζ in 
CM (r=0.83, p=0.0056, Fig.21B) and N cells (r=0.95, p=0.000019, data not shown), 
consistent with their dimerization in the TCR complex. This was not the case in EM cells 
(Fig.21B) that, as has been reported for effector cells (Krishnan, Warke et al. 2001), may 
regulate their ζ chain independently.  
 
 
 
 
Fig.21 In EM cells, SLP-76, LAT, PI3K and c-Cbl expression are co-regulated. 
(A) Correlation of the expression of SLP-76, LAT, PI3K with c-Cbl in 8 to 10 distinct subjects. The significance 
of their linear correlation is shown (Pearson r and p value<0.05). (B) Correlation of the expression of TCR/CD3 
ε and ζ components as described in A. 
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6.4 EM CD4 T cells show a lower functional threshold and 
differentially regulate TCR-mediated signals as compared to CM 
cells 
   EM CD4 T cells display immediate effector functions (Sallusto, Lenig et al. 1999) and 
produce IL-2 and IFN-γ in response to polyclonal stimulation with TCR/CD3 and CD28-
specific antibodies. In contrast, CM cells lack immediate effector functions and produce 
limited amounts of these cytokines, detectable only at high levels of TCR triggering 
(Fig.22A, left panel). In EM cells, CD28 co-stimulation enhanced significantly IL-2, but not 
IFN-γ production, while CD4 cross-linking had little effect (Fig.22A, right panel). Highly 
purified memory CD4 T cell subsets (purity>98%) were analyzed for their ability to 
proliferate following six days of polyclonal stimulation. EM cells were consistently more 
responsive and showed a lower threshold for proliferation than CM cells (Fig.22B, left 
panel). High level of TCR triggering (10 µg/ml of anti-CD3 antibodies) in the presence of co-
stimulation (1 µg/ml of anti-CD28 antibodies) induced proliferation of 20% of CM cells after 
six days (Fig.22B, left panel) consistent with low but detectable number of IL-2 producing 
cells following one night stimulation (Fig.22A, left panel). Under these conditions of 
stimulation (10 µg/ml anti-CD3 and 1 µg/ml anti-CD28 antibodies) roughly four times more 
EM cells were proliferating and producing IL-2 (Fig.22A and B, left panels). Proliferation of 
both cell subsets was highly dependent on CD28 co-stimulation. However, CD28 co-
stimulation and IL-2 impacted significantly stronger CM than EM cells (Fig.22B, right 
panel). At lower level of TCR triggering, this effect was even stronger with IL-2 inducing a 
9.3 and 1.8 fold increase in CM and EM cell proliferation, respectively (data not shown). In 
contrast, the analysis of 5 subjects revealed no significantly different intracellular calcium 
mobilization in CM versus EM cells (Fig.22C) upon TCR and CD28 crosslinking (CM: 
47.8% +/- 11.5 and EM: 38.8%+/-9.5, n=5, p=0.102).  
 
 
 
 
 
 
 
 
 
 
 -65- 
 
 
 
 
 
Fig.22 Functional threshold in CM and EM CD4 T cells. 
(A) Detection by FACS of intracellular production of IFN-γ and IL-2 in memory cells exposed for one night to 
graduated concentrations of immobilized anti-CD3 and 1µg/ml soluble anti-CD28 antibodies. Shown is one 
representative response out of four (left panel). Cumulated data of EM cells from four subjects in response to 5 
µg/ml of immobilized anti-CD3 antibody supplemented with 1 µg/ml soluble anti-CD28 or -CD4 antibodies are 
shown (right panel). (B) Proliferative potential of memory T cells measured by CFSE dilution in sorted CM and 
EM cells stimulated for six days as described in A (left panel). Shown are cumulated data of four subjects in 
response to 5µg/ml of immobilized anti-CD3 antibody supplemented with 1 µg/ml soluble anti-CD28 antibody 
in the presence or absence of IL-2 (right panel). (C) Intracellular calcium mobilization in CM and EM cells in 
response to graduated concentrations of soluble anti-CD3 and 1µg/ml soluble anti-CD28 antibodies (left panel). 
The percentage of cell showing changes in intracellular calcium concentration was assessed by measuring 
variations of FL5/FL4 ratio (right panel). 
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   Finally, in marked contrast to double positive thymocytes (Thien and Langdon 2005; 
Myers, Sosinowski et al. 2006) and consistent with observations in peripheral CD4 T cells 
from c-Cbl KO mice (Thien and Langdon 2005), the expression of TCR/CD3, CD4 or CD28 
at the surface of EM cells was not increased relative to CM cells (Fig.23). These observations 
indicate that CM and EM cells differentially regulate signalling pathways downstream the 
TCR. 
 
 
 
Fig.23 Surface expression of TCR/CD3ε, CD28 and co-receptors in memory T cell subsets.  
PBMC were stained with CCR7 and CD45RA and the expression of co-receptors, CD28 and TCR/CD3ε 
measured by FACS at saturating concentrations of antibodies in the different CD4 (A) or CD8 (B) T cell subsets. 
Shown are cumulated data of seven subjects relative to N cells. 
 
 
 
6.5 c-Cbl expression controls the functional threshold of EM CD4 T 
cells 
6.5.1 Cytosolic transduction to alter c-Cbl content of memory CD4 T cells 
   Consistent with their reduced expression of the negative regulator c-Cbl (Fig.18B and 
20A), EM cells show a lower threshold for activation (Fig.22A and 22B, left panels) relative 
to CM cells. These observations suggest that c-Cbl expression may control the functional 
response of memory cells. In order to verify this hypothesis, we increased c-Cbl content of 
EM cells and measured their functional responses. Ex vivo isolated T cells are refractory to 
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transfection and modulation of gene expression through viral infection remains suboptimal. 
Furthermore, the strong and sustained cell activation required for viral infection interferes 
with memory T cell differentiation and is incompatible with our study. To circumvent these 
limitations, we took advantage of the recently described cytosolic transduction peptide 
(CTP:YGRRARRRRRR) (Kim, Jeon et al. 2006). In particular, CTP peptide is derived by 
specific mutations of the protein transduction domain (PTD) of HIV TAT protein in order to 
induce a conformational change that inhibits nuclear transport without affecting the 
membrane transduction properties specific of TAT peptide (coil-structure responsible for 
importin-α binding converted in a more rigid α-helix unable to bind importin-α). Resulting 
CTP peptide promotes the delivery of CTP-fused protein selectively to the cytosol (Kim, Jeon 
et al. 2006).  
 
   CMV promoter-based expression vectors coding for CTP-GFP, CTP-c-Cbl (wt and C381A 
mutant) and a control CTP-fusion proteins (CTP-mock) were constructed in the laboratory 
(see MATERIALS AND METHODS for details). The C381A substitution in the RING 
domain of c-Cbl abolishes its interaction with E2 conjugating enzymes, thus preventing c-Cbl 
from functioning as an E3 ubiquitin ligase without affecting its association with signalling 
molecules (Joazeiro, Wing et al. 1999). Large-scale expression of CTP-fusion proteins in Hek 
293 cells was performed by the protein expression facility of the EPFL (Lausanne, 
Switzerland). CTP-proteins were purified from 3.2x108 cells/prep by nickel-affinity 
chromatography through recombinantly added N terminal 6xHis (CTP-mock and -GFP) or 
endogenously present 7xHis (aa36-42 in c-Cbl proteins, Fig.24). Both memory T cell subsets 
were transduced with comparable efficiency as assessed by transduction of low amounts of 
CTP-GFP (1.25 and 1.3 fold increase respectively, Fig.26A) or CTP-c-Cbl constructs (data 
not shown).  
 
 
 
Fig.24 Structure of recombinant CTP-c-Cbls. 
Positions of CTP peptide, HA-tag, endogenous 
7xHis-tag and C381A mutation are shown. 
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6.5.2 Impact of c-Cbl on CD4 memory T cell functions 
   To examine the impact of c-Cbl on the functional responses of EM cells, memory cells were 
transduced with wt and C381A mutant CTP-c-Cbls and stimulated with anti-CD3 and -CD28 
antibodies at concentrations (5µg/ml anti-CD3 and 1µg/ml anti-CD28) inducing EM but only 
limited CM cell functional responses (Fig.22A, 22B and 26C). Transduced wt and C381A 
mutant CTP-c-Cbls remained intact over the duration of T cell activation (Fig.26B) and 
showed comparable kinetics of degradation (data not shown). Furthermore while in EM cells 
the expression levels of Syk, LAT, SLP-76 and PI3K was not altered by CTP-c-Cbl 
transduction, TCR and CD28 triggering increased SLP-76 expression by 45% (Fig.25).  
 
 
 
Fig.25 Expression of signalling molecules in presence of CTP-c-Cbl transduction.  
Following transduction with CTP-c-Cbl, purified EM cells were stimulated with α-CD3 (5 µg/ml) and α-CD28 
(1 µg/ml) antibodies for 16 hours. Signalling components were quantified by RPP arrays and normalized to β-
actin. Colours indicate the mean log2 ratios of signalling components relative to resting non-transduced EM cells 
in 3 distinct subjects.  
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   Transduction of EM cells with CTP-c-Cbls impaired significantly their proliferation in a 
dose dependent manner whereas CTP-mock had no effect (Fig.26C). However, wt CTP-c-Cbl 
was 3-fold more potent (p<0.05) than C381A mutant (Fig.26C). Importantly, transduction of 
EM cells with CTP-c-Cbl increased their threshold for proliferation (Fig.26E) and their 
sensitivity to IL-2 (Fig.26F) thus restoring, at least partially, the functional phenotype of CM 
cells (Fig.22B, right panel).  
   In addition, wt CTP-c-Cbl specifically and significantly impaired IFN-γ and IL-2 production 
by 46% and 40%, respectively, while C381A mutant was significantly less efficient (p<0.05, 
Fig.26D). In contrast to cell proliferation, cytokine production was not further lowered by 
increasing the amount of wt CTP-c-Cbl transduced in memory cells (data not shown). 
Remarkably, these effects were obtained by increasing c-Cbl content of EM cells using CTP-
c-Cbl transduction (+55% in wt or C381A mutant CTP-c-Cbls, fig.26G) to that of CM cells 
(+34% average increase in CM cells as compared to EM cells, fig.18B and 20A) thus 
matching c-Cbl content in CM and transduced EM cells (data not shown). These data 
demonstrate that c-Cbl expression controls the functional phenotype of memory T cells 
through a mechanism mainly dependent of its E3 ubiquitin ligase activity, as evidenced by the 
weaker impact of enzymatically deficient c-Cbl C381A on EM cell functions. 
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Fig.26 Transduction of CTP-c-Cbl in EM cells results in lower functional response.  
(A) Limited amounts of CTP-GFP were transduced in memory cells and the transduction efficiency in CM and 
EM cells assessed by FACS. Thin and bold lines depict non-transduced and transduced cells, respectively. (B) 
Detection of c-Cbl following SDS-PAGE and immunoblotting of lysates of memory CD4 T cells previously 
transduced with wt or C381A CTP-c-Cbls and activated over night with anti-CD3 (5 µg/ml) and -CD28 (1 
µg/ml) antibodies. (C) Proliferative capacities of CM and EM cells as measured by H3 thymidine incorporation 
(left panel). Memory cells were transduced with increasing amount of wt and C381A CTP-c-Cbls fusion proteins 
(AU: arbitrary units), stimulated for 16 hours with anti-CD3 (5 µg/ml) and -CD28 (1 µg/ml) antibodies and their 
proliferation measured after three days. CTP-mock transduction was used as negative control (grey bar). Shown 
are data from four cumulated subjects (right panel). (D) Effect of CTP-c-Cbls transduction on memory T cell 
cytokine production in response to the stimulation described in C. Cytokine production was normalized to non-
transduced cells and CTP-mock transduction used as negative control. Significant changes (p<0.05) in the 
functions of transduced cells relative to control and mock-transduced cells are indicated () as well as p values 
for significant differences between wt and C381A mutant c-Cbls. (E) Effect of CTP-c-Cbl on the proliferation 
threshold of purified EM cells stimulated as described in C. One representative example out of three is shown. 
(F) Impact of CTP-c-Cbl transduction on the proliferation of EM cells in response to IL-2, anti-CD3 (3 µg/ml) 
and -CD28 (1 µg/ml) antibodies. Each set of linked dots correspond to a distinct subject and significant changes 
(p<0.05) between IL-2 treated and untreated cells are shown. (G) Quantification of the amounts of CTP-c-Cbls 
transduced in memory T cells relative to endogenous expression of c-Cbl following 16 hours of activation.  
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DISCUSSION & PERSPECTIVES 
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7.1 General discussion 
   The aim of this is the identification of the mechanisms responsible for the functional 
heterogeneity that characterizes human central (CM) and effector (EM) memory T cell 
subsets (Sallusto, Lenig et al. 1999). Since the surface expression of TCR/CD3 and co-
stimulatory receptor CD28 is comparable in the two cell subsets (Fig.23), we hypothesized 
that this functional heterogeneity derives from a differential use/regulation of the TCR 
signalling pathway. In particular, a different composition of their signalling machinery and/or a 
different assembly of their TCR-associated signalling complexes could be the basis of their 
heterogeneity. While the first aspect has been successfully addressed during this thesis, the 
second one remains under investigation. Indeed, although we developed a highly sensitive and 
quantitative system for profiling TCR signalling complex assembly (small scale affinity 
capture-RPP arrays, RESULTS section 5.5), we could not yet apply this methodology to CM 
and EM cells due to technical limitations related to their isolation procedure. Since FACS 
sorting is a long isolation procedure that is likely to interfere with memory T cell signalling 
(data not shown), cell isolation strategies based on beads were preferred for signalling 
assembly studies. However, to date no commercial systems (not interfering with cell 
activation and RPP arrays) reached a satisfactory level of purification. Alternative approaches 
are currently under investigation in collaboration with the EPFL (Lausanne, Switzerland).  
 
   In this study we report for the first time accurate ex vivo quantification of signalling 
components in human memory T cell subsets and demonstrate that the functional response of 
these subsets depends on specific variations in the expression levels of signalling proteins 
downstream of the TCR. Indeed, we demonstrate that the adaptor/regulator c-Cbl plays 
crucial roles in modulating the functional responses of EM cells through a mechanism mainly 
dependent on its E3 ubiquitin ligase activity.  
 
RPP arrays: a quantitative approach for profiling signalling proteins in memory T cell 
subsets 
   Efficient protein profiling of ex-vivo isolated human memory T cells has been possible due 
to the implementation of RPP array approach. Indeed, this technology posses sensitivity and 
performance characteristics that are largely beyond what traditional technologies (WB, Beads 
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suspension array) can reach. Moreover, the high degree of sensitivity, reproducibility and 
linearity achieved (Fig.14 and table 1), allowed excellent quantification of variations greater 
than 20% in protein modification or expression in as few as 20 cell equivalent per spot. The 
technical error, reflected by the normalized CV (normalized data CVsignalling protein+CVactin), was 
in the range of 11%. RPP array format displays the following technical advantages: i) it 
enables multiple sample to be analyzed under the same experimental conditions, thus 
simplifying quantitative comparison, ii) it allows inclusion of triplicate (or more) samples and 
dilution series in the same pad increasing robustness, accuracy and reproducibility of protein 
quantification and iii) it drastically reduces amounts of biological material, reagents, time and 
costs. 
   Compared to previous studies (Paweletz, Charboneau et al. 2001; Chan, Ermann et al. 2004; 
Tibes, Qiu et al. 2006), we improved the overall quality of the spots (smaller size, better 
circularity and higher reproducibility in spot intensity) without affecting the sensitivity, the 
dynamic range and the linearity of the detection. These improvements resulted in higher 
throughput potential and more accurate quantification.  
In addition, we implemented RPP array approach with respect to solubilization of lipid raft 
(Doucey, Legler et al. 2001) and efficient protein retention on 3D nitrocellulose in presence of 
detergent (Fig.13). The inconsistency observed between solubilization efficiency (Fig.13B) 
and RPP spot signal intensity (Fig.13A) using three distinct buffers (TX-, TX/SDS- and OG- 
containing buffers) confirmed that protein retention on 3D nitrocellulose substrate was 
heavily biased towards the detergent properties. OG-containing buffer was not affecting 
protein retention in the range of working protein concentration and resulted in better linearity 
and reproducibility relative to TX and TX-SDS buffers (Fig.13). The inclusion of TX in 
TX/SDS-containing buffer was necessary to decrease lysate viscosity and to prevent 
precipitation of SDS protein lysate at the temperature used for printing (<23˚C). Moreover, 
the implementations here discussed apply for the first time to human T cells isolated ex-vivo. 
   Only 0.7 nl of crude protein cell lysate was printed per spot, corresponding to 
approximately 2-20 ng of proteins. However, the printing robot requires handling of much 
larger volume (order of µl) due to limiting compatibility between the pin and the geometry of 
the sample-containing plate. Using pyramidal 384-well plate, we have already reduced the 
minimal workable volume to 3 µl. New types of plate are currently under investigation in the 
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laboratory. Remarkably, the sample amount required for the quantification a typical signalling 
protein by immunodetection of Western Blot (~300000 cells) was sufficient to print more 
than 4000 spots.  
   In order to profile proteins in such limited amounts of biological samples (2-20 ng/spot), a 
CARD amplification reaction has been introduced. Although this strategy is considered state 
of the art for RPP array detection, the amplification chemistry makes dual detection on the 
same spot difficult (data not shown) and limits multiplexing. Indeed interaction of biotinylated 
residues with fluorescent streptavidin (Fig.12B) produces a protein scaffold epitope masking 
of the lysate. Direct detection based on quantum dots (Geho, Killian et al. 2007) have been 
applied to overcome this limitation. Nevertheless, arrays can be printed in a multisector 
format (many pads identically printed in the same slide), allowing up to 16 analytes to be 
analyzed in the same samples at the same time. Remarkably, the inter-pad variability was in 
the same range of the inter-spot variability, making replicated pads almost identical 
(considering the technical error). 
   Housekeeping proteins are commonly used to normalize protein spot content, although 
some evidence supports that their expression in vivo are influenced by physiological and 
pathological factors (Ferguson, Carroll et al. 2005; Dittmer and Dittmer 2006). For that 
reason, quantification of total protein is often preferred for protein normalization (Winters, 
Dabir et al. 2007). The choice of actin as normalization protein in this study was justified by 
the absence of total protein quantification method compatible with the RPP array equipment 
available at the time when this project started. Furthermore, the use of actin but not β2-
microglobulin (Fig.15) nor tubulin (data not shown), has been validated by WB and RPP 
arrays in the cell subsets under study. Future effort will be addressed to validate total protein 
staining method such as colloidal gold (Winters, Dabir et al. 2007) and Sypro Ruby (Grubb, 
Calvert et al. 2003) as possible normalization means. However, activation-induced degradation 
of specific signalling components such as observed for ZAP-70 (Penna, Muller et al. 1999) 
represents a severe limitation to these total protein normalization approaches when 
phosphorylation state are profiled. In these studies, normalization to the pan-specific form of 
the phosphorylated target signalling protein are preferred. Ideally, a normalization strategy 
would allow reversible stain of the normalization protein coupled to detection of target 
signalling protein on the same spots, thus further reducing the technical error. 
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   The major limitation of RPP array technology lies in its dependency on antibody 
availability. However, most of the antibodies suitable for western blotting immunodetection 
work in this format, provided that they have no cross-reactivity with other protein in the 
sample analyzed (50-70% of the Abs). Moreover this technology requires the handling of 
highly purified cell populations.  
 
c-Cbl plays critical roles in controlling the functional heterogeneity of human memory 
CD4 T cell subsets 
   RPP arrays have been used in this thesis to profile the abundance of 15 relevant signalling 
proteins downstream of the TCR in human CD4 and CD8 memory T cell subsets (see 
RESULT section 6.1). Although CD8 memory subsets had a homogenous composition of 
their signalling machinery, it is worth emphasizing that CM cells appeared more closely 
related to N than EM or E cells (Fig.18A), in agreement with their gene expression and 
cytokine signalling profiles (Willinger, Freeman et al. 2005). In contrast to CD8 cells, CD4 
memory T cell subsets showed more profound changes in the expression levels of specific 
signalling components. 
   The lineage relationship between the different T cell subsets remains controversial. Our 
study could not directly address this relationship since was not focussed on a precise antigen-
specific population but examined the whole (heterogeneous) repertoire of central and effector 
memory cells. However, despite the relatively small number of molecules analyzed, our 
findings for both CD8 and CD4 cells suggest that CM cells may represent an intermediate 
population in the transition from N to EM cells. Indeed, the expression levels of the majority 
of molecules analyzed were gradually regulated along the N-CM-EM differentiation pathways 
while none was truly cell subsets-specific. These observations could be consistent with the 
progressive differentiation model proposed by Lanzavecchia and colleagues (low Ag dose: N-
non effector-CM, high Ag dose: N-effector-EM, see INTRODUCTION section 1.2.3.2) 
(Lanzavecchia and Sallusto 2002). 
   In CD4 EM cells, reduced expression of c-Cbl was significantly associated with lower 
expression of c-Cbl kinases (Fyn and Syk) and altered expression of the TCR key adaptors 
LAT and SLP-76 (Fig.18B). Of note, the expression levels of the related kinases Lck and 
ZAP-70 (functionally homologous to Fyn and Syk, respectively) that do not phosphorylate c-
Cbl, remained unchanged. This selective regulation may be a mechanism to further impairs c-
Cbl functions in EM cells by decreasing its phosphorylation and its E3 ligase activity. 
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However, this hypothesis remains to be investigated (see DISCUSSION and 
PERSPECTIVES section 7.2). Of note, increased expression of Syk in human CD4 effector 
cells differentiated in vitro was found to be associated with TCR signalling through FcRγ/Syk 
complex in place of CD3ζ/ZAP-70 in naïve cells (Krishnan, Warke et al. 2003). Along the 
same lines, ZAP-70 deficient patients expressing high level of Syk show impaired CD3-
mediated proliferation and IL-2 secretion (Noraz, Schwarz et al. 2000).  
   In addition, our data showed that exclusively on EM cells the expression level of c-Cbl 
correlates with that of PI3K, SLP-76 and LAT (Fig.21A), thus suggesting that the two 
memory subsets may possess a different organization of their signalling machinery. Of 
interest, inactivation of c-Cbl was reported to alter the functions of PI3K (Jeon, Atfield et al. 
2004), SLP-76 (Carpino, Turner et al. 2004) and LAT (Noraz, Schwarz et al. 2000; Carpino, 
Turner et al. 2004) and consequently to interfere with T cell development and activation.  
Importantly, the differences identified in the expression levels of these signalling proteins are 
likely to derive from a post-transcriptional regulation. Indeed, the transcription of the 
corresponding genes was not reported as significantly altered in CD4 memory T cell subsets 
(Chtanova, Newton et al. 2005; Riou, Yassine-Diab et al. 2007). 
   Cumulated analysis of the data revealed that the inter-subjects heterogeneity was increasing 
in both CD4 and CD8 cells with cell differentiation. Moreover, we observed a marked high 
inter-subject heterogeneity which was dependent on precise signalling component/T cell 
subset combination (Fig.19). This is likely to reflect inaccurate cell subset delineation based 
on partial phenotypical and functional correlates. The inclusion of CCR7 as a subset marker is 
justified due to the very clear correlation with cytokine secretion (Sallusto, Lenig et al. 1999; 
Geginat, Sallusto et al. 2001; Geginat, Sallusto et al. 2003). However, more recently CD4 
cells were shown to be distributed among six major compartments with EM cells (CD28+, 
CCR7-, CD45RA-) having the greatest capacity to produce IL-2, IFN-γ and TNF-α in 
response to Staphylococcal Enterotoxin B (SEB) stimulation and showing proliferation when 
co-cultured with autologous monocytes and exposed to PHA (Amyes, McMichael et al. 
2005).  
   In keeping with previous studies (Sallusto, Lenig et al. 1999; Geginat, Sallusto et al. 2001), 
our data showed that in response to CD3 and CD28 stimulation, EM cells have a higher 
capacity for cytokine production and a lower threshold for proliferation than CM cells 
(Fig.22). The latter observation is not in contrast with the higher proliferative capacity (i.e. 
expansion potential) of CM as compared to EM cells (Sallusto, Geginat et al. 2004). 
Moreover, CM cells produced IL-2 in response to EBV or CMV antigens (Amyes, 
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McMichael et al. 2005; Harari, Vallelian et al. 2005) or when triggered with anti-CD3 
antibodies and PHA (Sallusto, Lenig et al. 1999), but not in response to anti-CD3 and anti-
CD28 antibodies (Fig.22A). These results indicate that IL-2 production in CM cells may 
require additional triggering to TCR and CD28. The significance of the increased SLP-76 
expression following CD3/CD28 stimulation in EM cells (Fig.24) remains to be investigated, 
but underline the dynamicity and plasticity of the TCR signalling pathway in activated cells. 
   Our results are in marked contrast with CD4 peripheral T cells from c-Cbl KO mice, which 
show a higher functional threshold and are likely to arise from altered thymic selection and to 
reflect unbalanced c-Cbl and Cbl-b expression (Naramura, Jang et al. 2002). While c-Cbl and 
Cbl-b have been reported to be functionally redundant (Naramura, Jang et al. 2002), their 
specific substrates are cell type dependent and their regulatory effects controlled by their 
relative abundance (Dikic, Szymkiewicz et al. 2003). Indeed, the functional phenotype of c-
Cbl KO thymocytes and peripheral cells differed dramatically, consistent with high 
expression of c-Cbl in thymocytes and preferential expression of Cbl-b in mature CD4 T 
cells. c-Cbl KO thymocytes exhibit hyperphosphorylation of ZAP-70 and ERK1/2, and TCR 
signalling uncoupled from CD4 co-stimulation requirements leading to increased proliferation 
(Murphy, Schnall et al. 1998), intracellular calcium mobilization (Joazeiro, Wing et al. 1999) 
and TCR/CD3ζ degradation (Myers, Sosinowski et al. 2006). Finally, positive selection is 
enhanced in CD4 c-Cbl KO thymocytes that express higher levels of TCR, CD3, CD4, CD5 
and CD69 at their surface (Murphy, Schnall et al. 1998; Joazeiro, Wing et al. 1999). We 
reported similar expression of Cbl-b in CM and EM cells and reduced expression of c-Cbl in 
EM cells, leading to lower proliferation threshold, increased cytokine production but 
comparable intracellular calcium mobilization and expression of TCR/CD3, CD4 and CD28 
(Fig.18, 20, 22, and 23). Consistent with our data, cells from double Cbl KO mice show 
phenotype and functions of EM cells (Naramura, Jang et al. 2002), underling that the balance 
between c-Cbl and Cbl-b expression might be fundamental in controlling the functional 
phenotype of human memory cells. Of interest, c-Cbl acts as negative regulator of TCR-
mediated signals while functioning as positive regulator of PI3K by recruiting this protein to 
the cell membrane (Ueno, Sasaki et al. 1998; Lazaar, Krymskaya et al. 2001). Of note, this 
property is mediated by Tyr731 (docking site for SH2 domain of p85 regulatory subunits of 
PI3K), that is unique of c-Cbl but not Cbl-b (Thien and Langdon 2005). In line with this 
observation, CD28 stimulation (which activate PI3K pathways) impacted more strongly CM 
(which display higher expression levels of c-Cbl) than EM cells (Fig.22B).  
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   Our data showed that the expression levels of c-Cbl decrease from N to EM cell. 
Conversely, the proliferation rate of these cells decrease from EM to N cells (4.7%, 1.5% and 
0.2% per day in EM, CM and N, respectively) (Macallan, Wallace et al. 2004). In addition, 
the enhanced survival of CM versus EM cells has been associated to lower transcription of 
anti-apoptotic genes by inactivation of FOXO3a transcription factor. Complete inactivation of 
FOXO3a is optimally achieved through the convergence of signals from engagement of γc 
cytokine (IL-2 or IL-7) and antigen-specific TCR via activation of the common mediator 
PI3K (Riou, Yassine-Diab et al. 2007). Since c-Cbl may act as positive modulator of PI3K 
(Ueno, Sasaki et al. 1998; Lazaar, Krymskaya et al. 2001), its regulation during the 
differentiation from N to EM cells may represent a key point to modulate the responsiveness 
to survival/homeostatic signals of these cells. Consistently, c-Cbl was shown to enhance 
mitogenic and survival signals triggered through IL-4 (Ueno, Sasaki et al. 1998) and IL-2 
(Gesbert, Garbay et al. 1998) receptors (in B and T cell systems, respectively) by linking the 
PI3K pathway. 
   Together, our data indicate that CM and EM cells differentially regulate the signalling 
pathways downstream their TCR and that c-Cbl may play central role in controlling the 
functional response of these cells. In order to verify this hypothesis, we increased c-Cbl 
content of EM cells as endogenously expressed in CM cells by cytosolic-mediated protein 
transduction (CTP) to measure the impact on their functional responses. CTP approach 
represents an attractive alternative strategy to virus-mediated and interfering RNA-based 
alteration of gene expression that are inappropriate to the study of memory T cell activation 
(see RESULTS section 6.5.1). Moreover, the time window necessary to obtain an efficient 
protein regulation through these approaches is probably too long to avoid phenotypical and 
functional differentiation of the memory subsets analysed. In addition, CTP peptide derives 
from the protein transduction domain (PTD) of HIV TAT protein which has been extensively 
documented with regard to its membrane transduction potential in T cells, as well as its 
efficient delivery of biomolecules in vivo (Morris, Depollier et al. 2001).  
   Increased expression levels of c-Cbl in EM cells by CTP-c-Cbl transduction correlated with 
increased threshold for proliferation and impairment of cytokine production, thus confirming 
the important role of c-Cbl in controlling the functional phenotype of central and effector 
memory cells. Importantly, we reported that IL-2 impacted more strongly the proliferation of 
CM cells than EM cells (Fig.22B). In agreement with this observation, IL-2 treatment 
reversed the proliferation defect of EM cells induced by CTP-c-Cbl transduction (Fig.26F). 
Finally, the weaker impact of enzymatically deficient CTP-c-Cbl C381A mutant on EM cell 
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proliferation and cytokine production (Fig.26) is supportive of a mechanism mainly mediated 
by the RING finger domain and likely to involve multiple targets. Transduction of larger 
amounts of c-Cbl in memory cells failed to further reduce their cytokine production, 
suggesting that besides c-Cbl, TCR/CD28 engagement triggers additional negative regulatory 
pathways for the fine-tuning of TCR signalling. Possible additional regulators include the 
phosphatases SHP-1, SHP-2 and PEP (Hasegawa, Martin et al. 2004) or the C-terminal Src 
Kinase Csk (Brdicka, Pavlistova et al. 2000), the antagonist of receptor tyrosine kinase 
Sprouty 1 (Choi, Cho et al. 2006), the inhibitory adaptor Gab2 (Yamasaki, Nishida et al. 
2001) and the suppressor of T cell signalling Sts (Carpino, Turner et al. 2004). 
 
Together, our data support an important role for adaptor/regulator c-Cbl in the biology and 
function of memory cells. Indeed, regulation of c-Cbl expression in memory cells may be a 
key control point for balancing TCR and CD28/cytokines mediated signals towards enhanced 
effector functions (EM cells) or long term survival (CM cells). Consistently, increased 
expression levels of c-Cbl in CM cells may determine decrease sensitivity to TCR stimulation 
while enhancing the capacity of these cells to respond to survival signals. Latter signals may 
include both co-stimulatory signals through CD28 and signals from cytokines involved in 
long-term maintenance of memory cells, such as IL-7 and IL-15. Moreover, the progressive 
regulation of c-Cbl expression levels (N-CM-EM) may reflect a differentiation program that 
naïve cells undergo during the primary immune response, leading to the generation of the 
different memory subsets. In order to validate this model, however, the role of c-Cbl in 
modulating the responsiveness of the memory cell subsets to survival signals should be 
addressed (see DISCUSSION and PERSPECTIVES section 7.2). 
 
In conclusion, our work demonstrates for the first time the pivotal role of c-Cbl in the control 
of the heterogeneity and the plasticity of the functional phenotype of human memory CD4 T 
cell subsets. Moreover, it validates the combined use of RPP arrays and cytosolic transduction 
approaches as a powerful tool to quantitatively analyze signalling proteins and functionally 
assess their roles.  
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7.2 Perspectives 
The work reported in this thesis highlighted the pivotal role of c-Cbl in generating the 
functional heterogeneity of human central and effector memory CD4 T cells. However, 
although we demonstrated a clear correlation between the expression level of this 
adaptor/regulator and the functional responses of CD4 memory cells, further efforts are 
necessary to clarify the signalling events involved and the precise impact of c-Cbl on the TCR 
signalling pathway. To this end, we plan to characterize the specific usage of the signalling 
pathways downstream the TCR in CM and EM cells, as well as in EM cells where the content 
of c-Cbl has been modulated using CTP-c-Cbl transduction. This analysis will include the use 
of specific kinase inhibitors, the profiling of the phosphorylation state of critical signalling 
proteins by RPP arrays (resting state and following TCR and/or CD28 triggering), and the 
profiling of TCR signalling complex assembly by using the approach that we recently 
developed (small scale TCR affinity capture-RPP arrays, see RESULTS section 5.5).  
 
   In addition, our data suggest that c-Cbl may represent a key control point for balancing 
TCR and CD28 mediated signals in memory cells, leading to their specific functional 
phenotype. Indeed, in CM cells, increased c-Cbl content promotes higher negative regulation 
of TCR signalling pathway, dampening their functional properties, while possibly enhancing 
CD28-mediated signals, leading to increased survival potential (see DISCUSSION and 
PERSPECTIVES section 7.1). Consistently, CM cells appear significantly more sensitive to 
CD28 than EM cells (see RESULTS section 6.4).  
Moreover, experimental evidence proved that c-Cbl could enhance survival-mediated signals 
triggered by cytokines receptors (Gesbert, Garbay et al. 1998; Ueno, Sasaki et al. 1998). 
Therefore, differential c-Cbl expression level in memory cells may be implicated in the 
control of their long-term maintenance. 
In order to test this hypothesis, we plan to characterize by taking advantage of the cytosolic 
transduction approach described in this thesis the role of c-Cbl as possible enhancer of CD28 
and cytokine signals. Of particular interest is to understand how c-Cbl may regulate a 
differential responsiveness to homeostatic cytokines (such as IL-7 and IL-15) in central and 
effector memory cells.  
Finally, we would like to investigate if the different expression levels of c-Cbl in the memory 
subsets could reflect a step in the differentiation process. To achieve this aim, we plan to 
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follow by RPP array the regulation of c-Cbl following in vitro differentiation of CM to EM 
cells. 
 
   In addition, it would be interesting to assess if the differential composition/organization of 
the TCR signalling machinery in the memory T cell subsets may drive (or result from) a 
differential association of TCR and CD28 molecules at the cell membrane. Indeed, 
preliminary data from our laboratory suggests that TCR/CD28 are mainly pre-associated in 
EM but not CM cells and that this pre-association in EM cells is enhanced following cell 
activation. 
 
   Together, defining the mechanisms at the basis of the functional phenotype of memory T 
cells is crucial to better design efficient T-cell vaccine strategies. Moreover, such knowledge 
might favor the development of pharmacological treatments, concomitant to vaccination, able 
to promote following vaccination the generation and time-life maintenance of the memory 
cell subset that correlate with efficient protective immunity. Finally, since c-Cbl mutations 
observed in acute myeloid leukaemia were associated with increased proliferation (Caligiuri, 
Briesewitz et al. 2007; Sargin, Choudhary et al. 2007) and reduced expression of Cbl occurred 
in HIV-positive patients (Leng, Borkow et al. 2002), a better understanding of Cbl expression 
and action in memory cells might also contribute to the development of novel therapeutic 
approaches to control lymphocyte functions. 
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Antibodies and reagents. Mouse anti-TCR/CD3 Ab (OKT3) was affinity purified from 
hybridoma supernatant (American Type Culture Collection, ATCC, Rockville). Goat anti-
CD3ε chain (M20), rabbit anti-Lck (aa 475-505), goat anti-Cbl-b (C-20), rabbit anti-PLCγ 
Abs were purchased from Santa Cruz Biotechnology. The following rabbit Abs were obtained 
from Cell Signaling Technology: anti-ZAP-70 (99F2), anti-p38 MAP Kinase, anti-p44/42 
MAP Kinase, anti-Syk. Rabbit Abs against Lck (aa 1-58) and FcεRI γ-subunit (aa 80-86) 
were purchased from Upstate Biotechnology (Millipore). Mouse monoclonal Abs against 
CD28 (CD28.2), CD3ζ chain (8D3), TCR/CD3 (UCHT1), PI3 Kinase p85α subunit (4), c-Cbl 
(17), SLP76 (8), LAT (45), Actin (C4), CD45RA-PE (HI100), INFγ-APC (B27), and rat Abs 
against CCR7 (clone 3D12) and IL2-PE (MQ1-17H12) were purchased from BD 
PharMingen. Rabbit anti-actin (AC-40), anti-Hsp-90 Abs were obtained from Sigma-Aldrich 
and anti-beta2-microglobulin Ab was from BioVendor Laboratory Medicine. Purified rabbit 
anti-RNAse2, rabbit anti-Fyn and mouse anti-CD4 (B66-6) Abs were kindly provided by Drs. 
J. Hofsteenge (FMI, Basel, Switzerland), M.F. White and D. Rimoldi (LICR, Epalinges, 
Switzerland), respectively. Goat anti-rat IgG(H+L)-FITC Ab was purchased from 
SouthernBiotech and streptavidin-Cy3 was from Jackson ImmunoResearch Laboratories. The 
following horseradish peroxidase (HRP)-conjugated Abs were purchased by BD PharMingen: 
goat anti-mouse IgG and goat anti-rabbit IgG. Goat anti-mouse IgG1 Ab was from Santa Cruz 
Biotechnology and rabbit anti-goat IgG-HRP Ab was purchased from DAKO or Zymed 
laboratories.  
All chemicals unless indicated otherwise were from Sigma-Aldrich. 3% Blocking solution 
and Tyramide Amplification Reagent were purchased from Bio-Rad Laboratories. 
RPMI1640+GlutamaxTMI, Dulbecco's Modified Eagles Medium (DMEM), 
penicillin/streptomycin antibiotics and Fetal Bovine Serum (FBS) were from Gibco BRL 
(Life Technologies). FACS-Perm2 solution and GlogiPlugTM were purchased from BD 
Bioscience. SuperSignal® West Pico Chemiluminescent substrate was from Pierce and 
carboxyfluorescein diacetate succinimidyl ester (CFSE), Indo1 AM, red-fluorescent 
dimethylacridinone (DDAO), magnetic protein A beads and CD4 negative immunomagnetic 
depletion kit were from Invitrogen. Human recombinant interleukin 2 (IL-2) was purchased 
by RnD Systems and LymphoPrep™ was from Axis-Shield. Restriction enzymes were from 
Roche Applied Science and ligation Kit was from Takara Bio Inc. DNA purification kits were 
purchased from Macherey-Nagel GmbH and PfuTurbo® DNA-Polymerase was from 
Stratagene. 
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Cells, T cell isolation and lysis. HEK 293 cells were obtained from ATCC and maintained in 
DMEM supplemented with 10% FBS and penicillin/streptomycin antibiotics. Peripheral 
blood mononuclear (PBMC) specimens from healthy donors were obtained from the local 
blood bank and lymphocytes were enriched by LymphoPrep™ (Axis-Shield) gradient 
centrifugation. Following CD4 negative immunomagnetic depletion (Invitrogen), CD4 T cells 
were lysed (80×106/ml) for 2h on ice in the following buffers supplemented with 1 mM 
Na3VO4, 15 mM NaF and EDTA-free complete protease inhibitor cocktail (Roche): i) Octyl-
β-D-glucopyranoside-containing buffer: 100 mM Na2HCO3 pH 8.0, 80 mM Octyl-β-D-
glucopyranoside, 5 mM EDTA, 1 % (v/v) glycerol, 2% (v/v) 2-mercaptoethanol, ii) Triton X-
100-containing buffer: 100 mM Na2HCO3 pH 8.0, 0.3% TX-100, 300 mM NaCl, 5mM 
EDTA, 5mM EGTA, 5% glycerol, 1% 2-mercaptoethanol, iii) Triton/SDS-containing buffer: 
100 mM Na2HCO3 pH 8.0, 0.3% TX-100, 2% SDS, 100 mM NaCl, 5mM EDTA, 5mM 
EGTA, 5% glycerol, 2% 2-mercaptoethanol. Lysates were clarified by centrigugation 
(10000g, 10 min) and the supernatants heated for 10 min at 95°C. Alternatively, lysates 
(soluble fractions) and pellets (insoluble fractions) were boiled in SDS-PAGE protein loading 
buffer and analyzed by SDS-PAGE followed by gel staining with colloidal Coomassie 
Brilliant Blue. Proteins were quantified using Image J 1.34s image processing software 
(National Institute of Health, USA). 
For protein profiling experiments, CD8 and CD4 T cell subsets were isolated at 4°C by 
positive immunomagnetic selection (Miltenyi Biotech and BD Biosciences) followed by 
staining with mAbs specific for rat anti-CCR7, anti rat-FITC and CD45RA-PE and sorting 
into N (CCR7+, CD45RA+), CM (CCR7+, CD45RA-), EM (CCR7-, CD45RA-) and E 
(CCR7-, CD45RA+) populations using a Facs Aria cell sorter  (BD Biosciences). Purity of 
the isolated populations was 98% as assessed by FACS analysis. Cell were pelleted and lysed 
in Octyl-β-D-glucopyranoside-containing buffer as previously described. Lysates were stored 
at –20°C for up to 6 months. For functional assays, CD4 memory cells were isolated by CD4 
negative immunomagnetic depletion (Invitrogen) supplemented with anti-CD45RA Ab 
(HI100). 
 
CD4 T cell activation and TCR complex capture/denaturation An aldehyde-derivatized 
glass microscope slide (Nexterion® Slide AL, Schott Nexterion) was sub-divided into 24 
wells of 2 mm in diameter using a silicone rubber manifold (Electron Microscopy Sciences). 
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All steps were performed in a humid chamber. Anti-TCR/CD3ε antibodies (OKT3 at 3mg/ml 
in 150 mM Na2HCO3 pH 8.0, 5% glycerol, 0.005% CHAPS) were covalently immobilized on 
aldehyde-derivatized glass surface by incubation for one hour at RT. Following 3 washes with 
PBS containing 0.1% Tween-20 (PBST), remaining reactive aldehyde groups were blocked in 
ethanolamine buffer (50 mM ethanolamine, 50mM Sodium Borate; pH 8.0) for 90 min at RT. 
The slide was subsequently washed 3 times with PBS-T, once with water and used 
immediatly. 
Ex vivo isolated CD4 T cells were stimulated for 20 min at 37˚C using anti-CD3ε/CD28 
coated beads. 6µl of protein A beads (Invitrogen) were incubated with 1 µg of anti-CD3ε 
(UCHT1) and 5µg of anti-CD28 (CD28.2) antibodies for 40 min at RT, washed twice with 
PBS and resuspended in 40µl of PBS. CD4 T cells (0.3 million) were incubated with 6 µl of 
UCHT1-coated beads at 37˚C. The stimulation was stopped at different times by adding 0.5 
ml of ice-cold PBS containing 1mM Na3VO4 to the bead-cell mixture. Following 
centrifugation (5 min, 1200g), the cells (50 M/ml) were lyzed for 4 h on ice in lysis buffer 
(1% Brij 78 in 50 mM Tris pH 7.5, 0.5 mM Na3VO4, 10 mM NaF and protease inhibitors) 
that solubilizes lipid rafts and keeps protein-protein interactions intact (Legler, Micheau et al. 
2003).  Lysates were subsequently clarified by centrifugation (10 min, 10000g). Coated beads 
were removed from the lysate with a magnet and a lysate equivalent to 0.5 M cells (10µl) 
distributed in three wells of the glass slide. The wells were covered with parafilm and 
following o/n incubation in a humid chamber, the wells were washed twice with ice-cold lysis 
buffer containing 0.3% Brij78. The captured complexes were collected in denaturing buffer 
(2% SDS, 2.5% 2-mercaptoethanol, 10% glycerol, 50 mM NaCl, 1.5 mM MgCl2, 1mM 
EDTA) heated at 96˚C. The content of 3 wells was successively collected with 4µl of 
denaturing buffer and stored at -20˚C. Ovalbumin (GE Healthcare Bio-Sciences AB) at the 
final concentration of 0.1 mg/ml was added to the mixture before printing. 
 
Array printing and staining. 3 to 5µl of T cell lysates (80×106 cells/ml) or TCR isolated 
complexes were transferred into a polypropylene pyramidal bottom 384-well plate (Laubsher 
Labs, Miecourt, Switzerland) and 0.7 nl of sample were printed with Omnigrid 300 contact-
printing robotic microarrayer (Genomic Solutions, Ann Arbor, MI) using a 75 µm SMP3 pin 
(TeleChem International Inc.) onto a 16-pad 3D nitrocellulose-coated glass slides (Fast slide) 
(Schleicher and Schuell). Spots were obtained by a single pin hit and all samples were printed 
in triplicate. Leak-proof incubation chambers allowed detection of each pad independently. A 
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T cell lysate serial dilution was printed on each pad to assess the dynamic range of detection 
(~1 nl of a lysate at a concentration of 2-100x106 T cells/ml equivalent to 2-100 T cells/spot 
and 200 pg-100 ng protein/spot). Before staining, slides were dried o/n at room temperature 
(RT), rinsed 3 times with PBS 0.1% tween20 (PBST) and blocked for two hours at RT in 
PBST containing 3% BioRad blocking solution. Staining was carried out using a catalyzed 
signal amplification system followed by fluorescent detection. Briefly, arrays were incubated 
with primary antibody diluted in PBST containing 3% fish gelatine at a concentration ranging 
from 1:300 to 1:1000 for 14 hours at 4°C, followed by HRP-linked secondary antibody at a 
concentration of 1:1000 for anti-mouse and 1:3000 for anti-rabbit/anti-goat for 60 min at RT. 
Between each following steps, arrays were rinsed 3 times and washed 3 times 5 min each in 
PBST. Signals were amplified by Tyramide Signal Amplification reaction according to 
manufacturer instructions (BLAST reagent, PerkinElmer, Boston, MA) for 10 min at RT, 
followed by staining with streptavidin-Cy3 for 45 min in PBST containing 1% BSA and 5% 
PEG-8000. Secondary antibodies did not cross-reacted with cell lysates or TCR-complexes as 
assessed by amplification and detection with secondary antibodies alone. An antibody was 
accepted and used for RPP arrays detection only if it detected by immunoblotting a single 
predominant band at the expected molecular weight in lymphocyte lysates (Fig 3D). 
 
Array detection and analysis. Cy3 fluorescent-stained slides were scanned on GenePix 
4000B microarray scanner (Axon Instruments, Molecular Devices, Sunnywale, CA) at 10 µm 
resolution and saved as 16-bit TIFF files. Images were analyzed with GenePix Pro 6.0 (Axon 
Instruments) and Excel software (Microsoft, Redmond, USA). Local background-subtracted 
average pixel intensities of individual spot were used to determine the mean value of triplicate 
spots (each sample printed in triplicate spots). Data were considered when signal intensities 
were included in the linear range of detection of the lysate serial dilution present in the same 
array. Mean values were then normalized to the mean values of corresponding actin signal 
and used for subsequent cumulative analysis of the subjects. Changes between two subsets 
were considered as statistically significant when i) higher than 20% (technical error <11%) ii) 
calculated p-value of two-tails paired t-test was less than 0.05. In heat-map graph, normalized 
data were logged in base 2, in order to compensate for the asymmetry introduced by the ratio 
used in the normalization to N cells (e.g quantification CM / quantification N). log2 ratios 
derived from the analysis of different subjects were cumulated by calculating the mean log2 
ratio for each signalling protein and displayed in continuous colour scale. In TCR complex 
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analysis, mean values of each TCR complex sample were normalized to the mean signal 
intensity of corresponding bait protein (CD3ε) signals. All statistical analyses were performed 
using GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, California, 
USA). The coefficient of variation (CV, defined as the standard deviation divided by the 
mean) data represent the mean CV value obtained for low to high protein concentrations of T 
cell lysates. 
 
Functional assay. Cells were stimulated in 96-well plates coated with anti-TCR/CD3 
(OKT3) Ab and indicated soluble antibodies at 1 µg/ml. Cytokine secretion was blocked with 
GlogiPlugTM transport inhibitor and intracellular IL-2 and INF-γ production were monitored 
by flow cytometry using FACSCaliburTM and FACSDiva software (BD Biosciences). 
Memory cells were surface stained for CCR7 (using anti-CCR7 and anti rat-FITC Abs), 
fixed/permeabilized with PERM2 solution according to the manufacturer’s instructions and 
stained with PE-conjugated IL-2 and APC-conjugated INF-γ Abs.  
For proliferation assays, cells (40 millions/ml) were reacted with 6 µM CFSE for 7 min at 
37°C and the reaction quenched with serum. CFSE-labelled cells were surface stained for 
CCR7 (anti-CCR7 and anti-rat A647 Abs) and sorted in CM and EM cell populations. After 6 
days of stimulation the percentage of proliferating cells were determined by cytoflorimetry 
based on their CFSE content. Alternatively, incorporation of H3 thymidine (MP Biomedicals) 
was measured over 24 hours 3 days post-activation. 
For calcium analysis, negatively selected memory cells were loaded with 1 µM Indo1-AM for 
one hour at 37°C and incubated with OKT3 and anti-CD28 (1 µg/ml) Abs on ice following 
surface staining of CCR7 as described above. Immediately after crosslinking with anti-mouse 
Ab, intracellular changes in calcium were monitored at 37°C with a LSRII cytometer (BD 
Biosciences) by measuring the FL5/FL4 ratio over 5 min. 
 
Plasmids. Cytoplasmic Transduction Peptide 512 (CTP) sequence and corresponding plasmid 
were kindly provided by Dr. Y-S. Bae (Sungkyunkwan Univerity, Suwon, Korea). 
Complementary forward (5’TATCGGATCCGCCACCATGTACGGACGCCGCGCACGCC 
GCCGCCGCCGCCGCGCTAGCTACCCTTATGATGTGCCAGATTATGC3’) and reverse 
(5’GGCCGCATAATCTGGCACATCATAAGGGTAGCTAGCGCGGCGGCGGCGGCGG
CGTGCGCGCGTCCGTACATGGTGGCGGATCCGA3’) primers coding for CTP-HA 
peptide were annealed by heating 5 minutes at 98°C, followed by cooling at 20 °C. After 
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phosphorylation of 5’ends, the fragment was inserted into pET21a vector (Novagen) digested 
with NdeI/NotI and the recombinant construct (pET21a-CTP-HA) transformed in E.coli 
DH5α (Invitrogen). Positive clones were identified by restriction analysis. Wt and C381A 
mutant c-Cbl cDNA were amplified by polymerase chain reaction (PCR) from plasmids 
kindly provided by Dr. S. Lipkowitz (Ettenberg, Keane et al. 1999) and Dr. W. Langdon 
(Thien, Blystad et al. 2005) and His-tagged GFP was obtained by PCR from pEGFP-CI 
vector (clontech). The following primer pairs were used: Fw_c-Cbl: 
GCGGCCGCCGGCAACGTGAAGAAGAG / Rev_c-Cbl: GCGCCTCGAGCTACTAGGTA 
GCTACATGGGCAGG and Fw_GFP: GCGCGGCCGCGCACCATCACCACCATCATGT 
GAG / Rev_GFP: GCCTCGAGCTACTACTTGTACAGCTCGTCCATGCCG. Amplified 
fragments were inserted into NotI/XhoI restriction sites of pET21a-CTP-HA vector and CTP 
constructs subcloned into pCRTM3 vector (Invitrogen) digested BamH1/XhoI. A pCRTM3 
derived vector containing only the sequences corresponding to CTP-HA was also built by 
subcloning the CTP-HA cassette of pET21a(+)-CTP-HA into pCRTM3 vector digested 
BamH1/XhoI (pCR3-CTP-HA). Sequences of all constructs were confirmed by DNA 
sequencing. A frameshift mutation of pCR3-CTP-HA-GFP construct (keeping intact only the 
CTP sequence while altering the frame of the GFP sequence) was used as CTP-mock and 
resulted in a CTP-tagged unrelated protein of ~33 KDa. Maps and details of the recombinant 
vectors built in this thesis are reported in Annex I. 
 
Purification of CTP-recombinant proteins and cell transduction. Large scale transient 
expression of CTP-proteins in HEK293 cells was performed at the Protein Expression Core 
Facility (http://pecf.epfl.ch/, EPFL, Lausanne, Switzerland). Cells (3.2x108/preparation) were 
lysed in 50 mM phosphate buffer, pH 7.6 containing 0.1 % Tween-20 and 0.2 M NaCl. CTP-
recombinant proteins were purified from cell lysate through binding to endogenous (N 
terminal 7xHis (aa 36-42) in c-Cbl wt and C381A) or recombinant (N terminal 6xHis in CTP-
mock and CTP-GFP) His-tag by nickel-agarose chromatography. CTP proteins were enriched 
100-fold by a step elution in 0.5 M imidazole and dialyzed o/n against PBS. Their sequences 
were confirmed by nano liquid chromatography mass spectrometry (data not shown). CTP-
proteins were transduced into T cells by incubation for 30 min at 37°C in RPMI containing 
0.5% gelatine. For exact determination of amount of transduced proteins, transduced cells 
were treated with trypsin (3 min, 37°C) to remove any CTP-Cbl potentially interacting with 
the cell membrane. 
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ANNEX I 
1) Map of bacterial expression vector pET21a(+)-CTP-HA. 
 
pET21a(+)-CTP-HA vector is derived from pET21A(+) vector (Novagen) and carries a 
cytoplasmic transduction peptide (CTP) sequence right after the starting metionine. Optional 
HA- and His-tag sequences are present at the N- and C-terminal of the cloning site, 
respectively. The cloning/expression region of the cloning strand transcribed by T7 RNA 
polymerase is shown below. 
 
Wt or C381A c-Cbls or N-terminal His-tagged GFP obtained by PCR have been inserted into 
NotI / XhoI restriction sites. A stop codon was added at the end of the inserted genes, 
resulting in a construct not transcribing the C-terminal His-tag sequence. 
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2) Map of mammalian expression vector pCR3-CTP-HA. 
 
pCR3-CTP-HA vector is derived from pCRTM3 vector (Invitrogen) and carries a cytoplasmic 
transduction peptide (CTP) sequence right after the starting metionine. Optional HA-tag 
sequence is present at the N-terminal of the cloning site. The cloning/expression region of the 
cloning strand transcribed by CMV promoter is shown below. 
 
Wt or C381A c-Cbls or N-terminal His-tagged GFP obtained by PCR have been inserted into 
NotI / XhoI restriction sites.  
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List of recombinant vectors built during this thesis. 
  
Bacterial (pET21a-CTP-HA) and mammalian (pCR3-CTP-HA) expression plasmids carrying 
the cytoplasmic transduction peptide (CTP) at the N-terminal of the multiple cloning site were 
build and used as backbone for the insertion of the various genes. Details regarding the 
expression products obtained are provided. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
